US20150264816A1 - Systems and methods for flexible electrodes - Google Patents

Systems and methods for flexible electrodes Download PDF

Info

Publication number
US20150264816A1
US20150264816A1 US14/729,027 US201514729027A US2015264816A1 US 20150264816 A1 US20150264816 A1 US 20150264816A1 US 201514729027 A US201514729027 A US 201514729027A US 2015264816 A1 US2015264816 A1 US 2015264816A1
Authority
US
United States
Prior art keywords
layer
electrode
conductive
polymer
depositing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US14/729,027
Inventor
Robert E. Askin, III
Scott D. Hiatt
Kenneth S. Guillory
Daniel McDonnall
Christopher F. Smith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ripple LLC
Original Assignee
Ripple LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ripple LLC filed Critical Ripple LLC
Priority to US14/729,027 priority Critical patent/US20150264816A1/en
Assigned to RIPPLE LLC reassignment RIPPLE LLC ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: ASKIN, ROBERT E., III, GUILLORY, KENNETH S., HIATT, SCOTT D., MCDONNALL, DANIEL, SMITH, CHRISTOPHER F.
Publication of US20150264816A1 publication Critical patent/US20150264816A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/24Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/25Bioelectric electrodes therefor
    • HELECTRICITY
    • H05ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
    • H05KPRINTED CIRCUITS; CASINGS OR CONSTRUCTIONAL DETAILS OF ELECTRIC APPARATUS; MANUFACTURE OF ASSEMBLAGES OF ELECTRICAL COMPONENTS
    • H05K3/00Apparatus or processes for manufacturing printed circuits
    • H05K3/10Apparatus or processes for manufacturing printed circuits in which conductive material is applied to the insulating support in such a manner as to form the desired conductive pattern
    • H05K3/12Apparatus or processes for manufacturing printed circuits in which conductive material is applied to the insulating support in such a manner as to form the desired conductive pattern using thick film techniques, e.g. printing techniques to apply the conductive material or similar techniques for applying conductive paste or ink patterns
    • H05K3/1241Apparatus or processes for manufacturing printed circuits in which conductive material is applied to the insulating support in such a manner as to form the desired conductive pattern using thick film techniques, e.g. printing techniques to apply the conductive material or similar techniques for applying conductive paste or ink patterns by ink-jet printing or drawing by dispensing
    • H05K3/125Apparatus or processes for manufacturing printed circuits in which conductive material is applied to the insulating support in such a manner as to form the desired conductive pattern using thick film techniques, e.g. printing techniques to apply the conductive material or similar techniques for applying conductive paste or ink patterns by ink-jet printing or drawing by dispensing by ink-jet printing
    • A61B5/04001
    • A61B5/0492
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/24Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/24Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/25Bioelectric electrodes therefor
    • A61B5/279Bioelectric electrodes therefor specially adapted for particular uses
    • A61B5/291Bioelectric electrodes therefor specially adapted for particular uses for electroencephalography [EEG]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/24Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/25Bioelectric electrodes therefor
    • A61B5/279Bioelectric electrodes therefor specially adapted for particular uses
    • A61B5/296Bioelectric electrodes therefor specially adapted for particular uses for electromyography [EMG]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/68Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6846Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
    • A61B5/6847Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive mounted on an invasive device
    • A61B5/685Microneedles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/02Details
    • A61N1/04Electrodes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/02Details
    • A61N1/04Electrodes
    • A61N1/05Electrodes for implantation or insertion into the body, e.g. heart electrode
    • HELECTRICITY
    • H05ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
    • H05KPRINTED CIRCUITS; CASINGS OR CONSTRUCTIONAL DETAILS OF ELECTRIC APPARATUS; MANUFACTURE OF ASSEMBLAGES OF ELECTRICAL COMPONENTS
    • H05K3/00Apparatus or processes for manufacturing printed circuits
    • H05K3/10Apparatus or processes for manufacturing printed circuits in which conductive material is applied to the insulating support in such a manner as to form the desired conductive pattern
    • H05K3/12Apparatus or processes for manufacturing printed circuits in which conductive material is applied to the insulating support in such a manner as to form the desired conductive pattern using thick film techniques, e.g. printing techniques to apply the conductive material or similar techniques for applying conductive paste or ink patterns
    • H05K3/1216Apparatus or processes for manufacturing printed circuits in which conductive material is applied to the insulating support in such a manner as to form the desired conductive pattern using thick film techniques, e.g. printing techniques to apply the conductive material or similar techniques for applying conductive paste or ink patterns by screen printing or stencil printing
    • HELECTRICITY
    • H05ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
    • H05KPRINTED CIRCUITS; CASINGS OR CONSTRUCTIONAL DETAILS OF ELECTRIC APPARATUS; MANUFACTURE OF ASSEMBLAGES OF ELECTRICAL COMPONENTS
    • H05K2203/00Indexing scheme relating to apparatus or processes for manufacturing printed circuits covered by H05K3/00
    • H05K2203/07Treatments involving liquids, e.g. plating, rinsing
    • H05K2203/0756Uses of liquids, e.g. rinsing, coating, dissolving
    • H05K2203/0759Forming a polymer layer by liquid coating, e.g. a non-metallic protective coating or an organic bonding layer

Definitions

  • FIG. 1 illustrates a cross-sectional view of one embodiment of an electrode.
  • FIG. 2 illustrates a top view of one embodiment of an electrode.
  • FIGS. 3A , 3 B, and 3 C are cross sectional views that illustrate three embodiments of electrodes.
  • FIG. 4A illustrates a cross sectional view of one embodiment of an electrode comprising two electrode interfaces.
  • FIG. 4B illustrates a cross sectional view of an electrode that includes a connector in electrical communication with an electrode interface.
  • FIG. 5 illustrates a cross sectional view of one embodiment of an electrode that includes an electronic package.
  • FIG. 6 illustrates a side view of one embodiment of an electrode that includes a printed circuit board, which is coupled to an optical transceiver and an application specific integrated circuit.
  • FIG. 7 illustrates a cross sectional view of one embodiment of a multi-layer electrode.
  • FIG. 8 illustrates a cross-sectional view of one embodiment of a multi-layer electrode and a connector.
  • FIG. 9 illustrates one embodiment of an electrode array.
  • FIG. 10A illustrates a block diagram of one embodiment of an implantable system that includes an electrode grid and a signal processing unit.
  • FIG. 10B illustrates a block diagram of one embodiment of a wireless system that includes an electrode grid, a telemetry module, and a receiver module.
  • FIG. 11 illustrates one embodiment of a system that comprises an electrode grid, a telemetry module, and a receiver module.
  • FIG. 12 illustrates one embodiment which includes components for electrical stimulation and/or recording as part of a biocompatible system.
  • FIG. 13 illustrates one embodiment of a method for manufacturing an electrode array and an associated telemetry module.
  • Electrodes may be flexible and/or stretchable, and interconnection structures that can be used both externally and/or implanted within the body. Electrodes according to various embodiments disclosed herein may be produced by depositing patterned layers of insulating and conductive polymers to form multi-layer circuits. The conductive materials and layers in the structure can be exposed on the surface of the structures for use as electrodes. A plurality of electrodes may be formed into an electrode array. In various embodiments, electrode arrays may be associated with telemetry modules configured to wirelessly exchange data between an implantable component and an external module.
  • Certain embodiments may be suited for short-term implantation, while other embodiments may be suited for long-term implantation. Still other embodiments may be used for in vitro applications.
  • Some applications of the systems and methods disclosed herein may include recording from and stimulation of neural tissue, stimulation of muscles, sub- and epi-dural monitoring, use in connection with a blink prosthesis, use in treating incontinence via posterior tibial nerve stimulation, use in restoring sexual function via stimulation of the spinal cord, use in recording implanted EMG and neural signals for use in prosthesis control, use in the stimulation of the recurrent laryngeal nerve for treatment of dystonia, use in stimulation of peripheral nerves for nerve block, and use in connection with neuroprosthetic and neural interface applications (e.g., a pacemaker device).
  • a pacemaker device e.g., a pacemaker device
  • exposed electrode areas can also be formed from a conductive polymer that is different from conductive polymers used within the structures.
  • electrodes on the surface of the structure can also be formed by embedding metal or other electrode materials into the structures, and connecting to them with conductive polymers. These electrodes may also include geometrical and structural features for penetrating into tissues, hooking or providing mechanical fixation, mitigating stress around flexion points, or increasing the surface area of the electrode.
  • conducting traces can also be brought to the surface of the structure to create contact pads for bonding to other devices, including sensors, actuators, or other devices or assemblies. Bonding can be performed by applying pressure to hold the conductive areas in contact with bond pads on the devices, or by applying conductive adhesives or joining materials. These joints can also be further encapsulated with insulating polymers, such as silicones to seal and/or structurally reinforce them.
  • electrodes may include embedded electronics.
  • Such electronics may include, but are not limited to, any combination of silicon integrated circuits (“ICs”), circuit boards with electronic components, hermetic enclosures with contacts and feed-throughs to internal electronics, and the like.
  • ICs silicon integrated circuits
  • These electronics may include amplifiers, filters, analog to digital conversion, digital signal processing, stimulators, control circuits, fail-safe monitoring, data error checking, batteries, and connections for data and power telemetry with external devices.
  • Flexible electrodes may be manufactured by any method for controlled dispensing and/or forming of insulating and conductive polymers into patterns, including: spraying polymer layers onto a surface; depositing polymer layers through needles and narrow dispensing nozzles, including those that use gas pressure and positive displacement for flow control; depositing polymer layers through an ink jet dispenser (such as picodot systems); depositing polymer layers by screen printing and printing through masks; using optical, plasma, or chemical methods to selectively activate areas of a substrate to facilitate selective coating of areas with patterns of polymers; using laser ablation, or plasma or chemical etching (including use of photolithography or overlay masks) to selectively remove and form patterns in layers of deposited polymers; and depositing polymer layers onto both 2D surfaces and 3D molds.
  • Electrodes may include any application for which electrodes are currently utilized. Certain embodiments may be employed for sensing of electrophysiological signals from cells, tissues, organs, and body parts, including signals from nerves and muscles, EEG, EMG, ECG, EOG, ERG, ENG, ECoG, EGG, LFP, single and multiunit action potentials, and evoked potentials. Sensing and recording can be performed at the cell, tissue, organ, and body part scales, and used for diagnostic purposes, construction of neuroprosthetic systems for functional restoration, and brain machine interfaces to control external devices based on neural and/or muscle signals. These devices can be used for implanted and external body surface applications, as well as for temporary insertion into and/or application to tissues and organs during surgery and diagnostic procedures, for both short- and long-term sensing purposes.
  • various embodiments disclosed herein may be utilized for electrical stimulation of cells, tissues, organs, and body parts, including stimulation of nerves and muscles, for diagnostic purposes, enhancing trophic effects, functional restoration or rehabilitation in Functional Electrical Stimulation (FES) and other neuroprosthesis systems, and neuromodulation applications including Deep Brain Stimulation (DBS) targets, the cerebral cortex, sympathetic and parasympathetic nerves, peripheral nerves, and the spinal cord.
  • FES Functional Electrical Stimulation
  • DBS Deep Brain Stimulation
  • These devices can be used for implanted and external body surface applications, as well as for temporary insertion into and/or application to tissues and organs during surgery and diagnostic procedures, for both short- and long-term stimulation purposes.
  • Still other embodiments may be utilized for sensing potentials and currents related to chemical reactions associated with the electrodes, including reactions for oxygen sensing, pH sensing, protein-specific binding of materials to the electrodes, and other chemical sensors based on electrodes. These may also include chemical modification and/or coating of the electrodes, or use of the electrodes with other application-specific materials necessary to sense these reactions.
  • Flexible electrodes may be also utilized for control or forcing chemical reactions associated with the electrodes, including release of chemicals or drugs, modification of the local chemical environment, and forcing of chemical reactions. These may also include chemical modification and/or coating of the electrodes, or use of the electrodes with other application-specific materials necessary to create or control these reactions. Various embodiments may also be utilized to control chemical reactions, such as gas evolution or pH changes to effect structural changes in materials, including inflation of balloons and changing the shape, rigidity and forces within the device.
  • Electrodes and biological material impedances may be collected, including fixed frequency impedance and multi-frequency impedance spectroscopy methods to characterize electrode interfaces and characteristics of cells, tissues, organs, and body parts of humans and animals, including nerve, muscle and dental tissues. Such measurements may include frequency, phase, and all other measures used to characterize impedances.
  • Still other uses of flexible electrodes may include measurements of biological material impedances, which may used to compute impedance tomography images at the cell, tissue, organ, and body scale; application of potentials for electrophoresis, microelectrode array dish, and other in vitro applications; application of potentials for electroporation and other electrical modifications of tissues; and creation of voltage gradients to accelerate the delivery or migration of drugs.
  • adhesives may be applied to the structures to bond them to the body; coatings, such as hydrogels, PEG structures, or other biomaterials, may be used to modulate the tissue response to the structure, including coatings that release drugs for this purpose; coatings may be applied to the electrode to change the adhesion of body tissues to the structures; drugs may be embedded within the non-conducting or insulating material that are released over time to affect the biocompatibility and local tissue response to the implanted structures; chemical surface modification (e.g., hydrophobic, hydrophilic, or non-stick materials) may be utilized to affect the interaction of the surfaces with materials in the environment or biocompatibility in the body; nanomaterials or coatings (e.g., iridium, conductive polymers, or carbon nano-tubes) may be applied to electrodes to affect their biocompatibility and impedance; radio-opaque alignment markings, identification information, and/
  • Flexible electrodes disclosed herein may be implanted into the body with a variety of methods, including: insertion into epidural and subdural spaces through openings in the cranium; folding/unfolding and/or rolling/unrolling to deploy the structure once inside the body; use of saline and/or air balloons within the structure to affect mechanical changes inside the body for fixation, application of pressure, guidance, manipulation of placement, or other purpose; use of guide needles and other surgical instruments to create pilot holes and channels for insertion of the structures into the tissue; and use of needles or other surgical instruments to push or pull the structures into the tissue, then removing the instruments while leaving the structures in place.
  • insulated conductors may be disposed within a flexible electrode.
  • Providing insulated conductors within the flexible electrode may also allow for the connection of embedded electrodes; the connection of probes and sensors (e.g., accelerometers, pressure sensors, optical and IR sensors, contact switches, magnetic field sensors, capacitive sensors, inductive coils, thermal flux sensors, temperature sensors, proximity sensors, piezo sensors, ultrasound transducers, sound sensors, etc.); the connection of actuators or devices (e.g., force generators, motors, piezo actuators, electromagnets, coils, inductors, ultrasound transducers, stimulators, light emitting diodes etc.); the formation of flexible elastic resistor and capacitor elements that can stretch around tissues and detect structural changes in the sensor by changes in electrical impedance in the sensor elements; the formation of capacitive shields and guard traces for protection of other traces within the structure from interference and electrostatic discharge (ESD); and the measurement of conductivity within the electrode and electrode structures to diagnose problems within the device structure.
  • probes and sensors
  • FIG. 1 illustrates a cross-sectional view of one embodiment of an electrode 100 , according to the present disclosure.
  • Electrode 100 includes an internal conductive polymer trace 104 that is disposed within an insulating polymer 106 .
  • An electrode interface 102 may be in electrical communication with internal conductive polymer trace 104 .
  • Internal conductive polymer trace 104 may also be in electrical communication with a connector 108 .
  • connector 108 may comprise a percutaneous or transcutaneous connector.
  • Insulating polymer 106 may comprise any flexible and/or elastomeric material that provides electrical insulation. According to various embodiments, insulating polymer 106 may comprise any combination of silicones, siloxanes, polydimethylsiloxane (PDMS), rubber materials, latex materials, polyesters, polypropylenes, polytetrafluoroethylenes (PTFE), Parylenes, liquid crystal polymers, polyimides, polyesterimides, polyamides, polybutyldienes (PBD), flexible copolymers, or any other polymer used for medical applications.
  • PDMS polydimethylsiloxane
  • PTFE polytetrafluoroethylenes
  • Parylenes Parylenes
  • liquid crystal polymers polyimides, polyesterimides, polyamides, polybutyldienes (PBD), flexible copolymers, or any other polymer used for medical applications.
  • Internal conductive polymer trace 104 may comprise polymers that are intrinsically conductive (including polypyrrole, polyacetylene, polyaniline or poly[dioctyl-bithiophene] (PDOT)), or polymers that are doped with conductive particles.
  • PDOT polypyrrole, polyacetylene, polyaniline or poly[dioctyl-bithiophene]
  • conductive particle may be utilized in connection with internal conductive polymer trace 104 , including any combination of: conductive forms of carbon (including graphite, carbon black, vitreous carbon, acetyl carbon, and carbon nantotubes); metal particles (e.g., particles of silver, gold, platinum, iridium, platinum-iridium alloys, titanium, tungsten, stainless steel); particles of other materials (e.g., nickel, ceramics, or carbon) that are coated with metals with higher contact conductivity (e.g., silver, gold, iridium, and platinum). Further, according to various embodiments, particles of shapes and morphologies may be utilized to better facilitate electrical contact between conductive particles in the polymer.
  • conductive forms of carbon including graphite, carbon black, vitreous carbon, acetyl carbon, and carbon nantotubes
  • metal particles e.g., particles of silver, gold, platinum, iridium, platinum-iridium alloys, titanium, tungsten, stainless steel
  • conductive particles may be pre-mixed into the polymer that is subsequently formed into an electrode, may be simultaneously mixed with a polymer and dispensed to form an electrode, or may be injected into a previously dispensed polymer layer with a carrier material (e.g., toluene or alcohol).
  • a carrier material e.g., toluene or alcohol
  • the design and manufacturing of the flexible devices may also include: use of polymers that are made conductive by filling with conductive particles, and in which the polymer shrinks to keep conductive particles in compression; polymers that shrink, expand, and/or soften after curing or when exposed to the body, to introduce stresses and/or shape changes into the material and/or other changes in mechanical compliance; substrate layers that are stretched during application of other layers, to keep the secondary layers in compression when the substrate is relaxed; other materials and fibers (including carbon or glass fibers) embedded into the structures to provide mechanical strain reinforcement and/or affect the mechanical properties of the structure in homogeneous and complex heterogeneous arrangements; coatings (such as polyethylene glycol) that stiffen the structure to aid insertion into tissues, that soften or dissolve away over time; formation of twisted-pair cables and/or cable ground planes within the structure; use of magnetic fields to manipulate conductive polymers with particles that respond to magnetic fields; plasma cleaning or other types of surface activation and adhesion promotion methods (such as silanes or other compounds)
  • FIG. 2 illustrates a top view of one embodiment of an electrode 200 according to the present disclosure.
  • Electrode 200 includes a plurality of internal conductive polymer traces 204 a - d surrounded by an insulating polymer 206 .
  • a plurality of electrode interfaces 202 a - d power in electrical communication with internal conductive polymer traces 204 a - d , respectively.
  • FIG. 2 illustrates an embodiment including four electrode interfaces 202 a - d associated with four internal conductive polymer traces 204 a - d , according to various embodiments, any number of electrode interfaces 202 may be utilized in connection with any number of internal conductive polymer traces 204 .
  • Internal conductive polymer traces 204 a - d are also in electrical communication with connector 208 .
  • FIGS. 3A-3C are cross sectional views that illustrate three embodiments of electrodes 300 a - c , which may be utilized in various embodiments.
  • FIG. 3A illustrates electrode 300 a , in which the same material forms both an internal conductive polymer trace 304 a and an electrode interface 302 a .
  • An insulating polymer 306 a is disposed around electrode interface 302 a and internal conductive polymer trace 304 a .
  • FIG. 3B illustrates electrode 300 b , in which an internal conductive polymer trace 304 b comprises one polymer, and an electrode interface 302 b comprises a second polymer.
  • An insulating polymer 306 b is disposed around electrode interface 302 b and internal conductive polymer trace 304 b .
  • FIG. 3C illustrates electrode 300 c , in which an electrode interface 302 c is comprised of metal.
  • Electrode interface 302 c is in electrical communication with an internal conductive polymer trace 304 c .
  • An insulating polymer 306 c is disposed around electrode interface 302 c and internal conductive polymer trace 304 c.
  • Electrode interfaces 302 a - c may, in various embodiments, include geometrical and structural features for penetrating into tissues, hooking or providing mechanical fixation, or increasing the surface area of the electrode. Bonding between electrode interfaces 302 b - c and internal conductive polymer traces 304 b - c can be performed by the application of pressure to hold the conductive areas in contact, or by applying conductive adhesives or joining materials. These joints can also be further encapsulated with insulating polymers such as silicones to seal and/or structurally reinforce them.
  • FIG. 4A illustrates a cross sectional view of one embodiment of an electrode 400 comprising two electrode interfaces 402 and 403 . Electrode interfaces 402 and 403 are in electrical communication by way of internal conductive polymer trace 404 . Electrode interfaces 402 and 403 and internal conductive polymer trace 404 are surrounded by insulating polymer 406 . Embodiments including multiple electrode interfaces, such as electrode 400 , may allow for the connection of other devices, including sensors, actuators, or other devices or assemblies to electrode 400 .
  • FIG. 4B illustrates a cross sectional view of electrode 400 that also includes a connector 408 in electrical communication with electrode interface 403 .
  • Various embodiments may also include connectors, including percutaneous connectors that pass out of the body.
  • Such connectors may, in various embodiments, be encased in titanium, sintered titanium, stainless steel, polymer fabrics, or other materials to facilitate better biocompatibility and infection resistance for percutaneous applications.
  • These connectors may also include screw holes, mounting flanges, rings, loops, fasteners, fabrics, or other structures for fixing the connector to tissue, skin, and/or bone.
  • FIG. 5 illustrates a cross sectional view of one embodiment of an electrode 500 that includes a printed circuit board 510 and various electronic components 512 , 514 , and 516 .
  • Electrode 500 also includes an electrode interface 502 in electrical communication with an internal conductive polymer trace 504 .
  • An insulating polymer 506 may be disposed around internal conductive polymer trace 504 , printed circuit board 510 , and various electronic components 512 , 514 , and 516 .
  • a variety of electronic components may be integrated with a printed circuit board 510 .
  • such electronic components may include amplifiers, stimulators, data transmission circuitry, light emitting diodes and/or photo sensing diodes, data processing circuitry, batteries, and/or circuitry for receiving power from an external power source.
  • FIG. 6 illustrates a side view of an electrode 600 that includes a printed circuit board 610 , which is coupled to a transceiver 620 , and an application specific integrated circuit 618 .
  • An insulating polymer 606 may be disposed around an internal conductive polymer trace 604 , printed circuit board 610 , application specific integrated circuit 618 , and transceiver 620 .
  • Wire leads 622 may electrically connect a printed circuit board 610 to application specific integrated circuit 618 .
  • Certain embodiments may utilize infrared data transmission in order to transmit data collected by electrode 600 to an external data receiver (not shown).
  • Such embodiments may comprise materials with optical properties selected for selective transparency to certain optical or infrared signals so that the device can use these wavelengths for telemetry.
  • insulating polymer 606 may be selected so as to provide minimal attenuation to an infrared data signal generated by transceiver 620 .
  • FIG. 7 illustrates a cross sectional view of one embodiment of a multi-layer electrode 700 .
  • Electrode 700 comprises a plurality of internal conductive polymer traces 706 a - d separated by a plurality of insulating layers 704 a - d .
  • Electrode 700 includes conductive vias 722 , 724 , 726 , 728 , and 730 that connect between internal conductive polymer traces 706 a - d and/or the surface of electrode 700 .
  • Electrode 700 includes through via 722 , which passes through all conductive layers to the surface of electrode 700 ; blind vias 726 , 728 , and 730 , which pass from the surface of electrode 700 to some conductive layers; and buried vias 724 and 725 , which are completely embedded within electrode 700 .
  • FIG. 8 illustrates a cross-sectional view of one embodiment of a multi-layer electrode 800 and a connector 808 .
  • Connector 808 may comprise a plurality of penetrating electrodes 809 , which although not shown in a grid configuration in FIG. 8 , may be arranged in a grid configuration.
  • a plurality of internal conductive polymer traces 806 a - h may be in electrical communication with the plurality of penetrating electrodes 809 .
  • a plurality of insulating polymer layers 804 a - g may be disposed between the plurality of internal conductive polymer traces 806 a - h . Accordingly, electrical signals may be confined to internal conductive polymer traces 806 , which may in turn be transmitted to an external connector.
  • FIG. 9 illustrates one embodiment of an electrode array 900 .
  • Electrode array 900 may include an electrode grid 930 that includes a plurality of individual electrodes. Although FIG. 9 illustrates a square electrode array 900 , having eight electrodes on each side, any number of configurations may also be utilized in alternative embodiments.
  • Each electrode in electrode grid 930 may be in electrical communication with an internal conductive polymer trace (not shown).
  • a plurality of internal conductive polymer traces may be grouped in one of a plurality of lead wires 932 .
  • Lead wires 932 may also be an electrical communication with the plurality of leads 934 . Electrical signals received by each of the plurality of electrodes in electrode grid 930 may be conducted to one of the plurality of leads 934 .
  • electrode array 900 may be utilized for intracranial epilepsy monitoring. Some of the patients suffering from epilepsy that do not respond adequately to drug therapies are candidates for surgical treatment to resect or disrupt seizure foci. In preparation for such a surgery, an electrode array, such as electrode array 900 , may be implanted over the focal areas for up to 30 days to accurately localize the seizure foci and minimize damage to surrounding cortical areas. According to various embodiments, electrode arrays may range in size from large grids (e.g., 9 cm ⁇ 9 cm) to small strips of electrodes (e.g., 1 cm ⁇ 6 cm). Additional embodiments include high density microECoG electrodes which may be present in conjunction with larger conventional cortical mapping electrodes.
  • lead wires 932 may connect the implanted electrode array to a neural instrumentation system (not shown), which records information regarding electrical conditions detected by the plurality of electrodes in electrode grid 930 .
  • Lead wires 932 may pass through the scalp of the patient. The use of percutaneous lead wires 932 may expose patients to a risk of infection.
  • FIG. 10A illustrates a block diagram on one embodiment of an implantable system 1000 A that includes an electrode grid 1030 and a signal processing unit 1034 .
  • system 1000 A may be utilized in a variety of applications, including deep brain stimulation and intracranial monitoring.
  • Electrode grid 1030 is in electrical communication with signal processing unit 1034 and may exchange data with signal processing unit 1034 . Data may be received by signal processing unit 1034 and recorded and/or data may be transmitted from signal processing unit 1032 to electrode grid 1030 in order to provide electrical stimulation. Data sent to or received from electrode grid 1034 may be conditioned by signal conditioner 1034 .
  • Such conditioning may include, in various embodiments, amplification, analog to digital conversion (e.g., conversion of analog data recorded by electrode grid 1030 to digital data), and digital to analog conversion (e.g., conversion of digital data from signal processing unit 1032 to analog data).
  • a microprocessor unit (“MCU”) 1036 may be in electrical communication with signal conditioner 1034 , and may record, analyze, and/or generate data signals received from work to be sent to electrode grid 1030 .
  • a battery 1037 may provide power to MCU 1036 and signal conditioner 1034 .
  • FIG. 10B illustrates a block diagram of one embodiment of a wireless system 1000 B that includes an electrode grid 1030 , a telemetry module 1031 , and a receiver module 1047 .
  • system 1000 may be utilized for intracranial epilepsy monitoring.
  • Telemetry module 1031 and receiver module 1047 may be configured to exchange data and power wirelessly across the patient's skin 1051 .
  • system 1000 does not include percutaneous lead wires, and accordingly, use of system 1000 may reduce the risk of infection to a patient associated with percutaneous lead wires.
  • the electrode grid 1030 is in electrical communication with a telemetry module 1031 .
  • Telemetry module 1031 includes an amplifier 1033 , which receives and amplifies signals collected by each of the plurality of individual electrodes.
  • Amplifier 1033 may comprise analog amplifier components, such as those available from Intan, Technologies, LLC of Salt Lake City, Utah. Amplified signals generated by amplifier 1033 may be converted to digital signals by ND converter 1035 .
  • A/D converter 1035 may also comprise a multiplexer configured to generate a digital output from a plurality of analog inputs.
  • a microprocessor unit (MCU) 1036 may receive and process the output of A/D converter 1035 .
  • MCU 1036 may comprise a commercially available microcontroller, or may comprise an application specific integrated circuit.
  • MCU 1036 may be embodied as a microprocessor in the TI MSP430 product family available from Texas Instruments of Dallas, Tex.
  • MCU 1036 may comprise both one-time programmable memory for core software storage and EEPROM memory for device serialization information and special feature programming.
  • MCU 1036 may prepare data to be transmitted by a data transceiver 1048 .
  • data transceiver 1048 may comprise an infrared transceiver, and infrared data may be transmitted via a Return to Zero (RZ) scheme with adaptive thresholding. If further DC balance is needed, 86106 or Manchester codes may be utilized. All data may include error-checking codes.
  • data transceiver 1048 may comprise a radio frequency data transmission system.
  • System 1000 may also include a receiver module 1047 , which may be separated from telemetry module 1031 by the skin 1051 of the patient.
  • Receiver module 1047 may comprise a data transceiver 1042 .
  • Receiver module 1047 and telemetry module 1031 may exchange data across the patient's skin using a bidirectional communications channel. Data received from telemetry module 1031 may include recorded data from electrode grid 1030 , while data transmitted to telemetry module 1031 may comprise data to provide stimulation using electrode grid 1030 .
  • Receiver module 1042 may further comprise a power transmitter 1046 , which is coupled to a coil 1044 .
  • Coil 1044 may be inductively coupled to coil 1040 .
  • Power transferred to coil 1040 may be provided to a circuit for power recovery 1037 , which may in turn provide power to A/D converter 1035 and amplifier 1033 .
  • inductive coupling between coil 1044 and coil 1040 may also be used to transmit data.
  • Circuitry for power recovery circuit 1037 may comprise a resonant full-wave rectifier (not shown) and filter with a low drop-out linear regulator (not shown). Circuitry for power recovery 1037 may also include the ability to measure the over-voltage of the rectifier and pass the signal to MCU 1036 for sampling.
  • This signal passed from circuitry for power recovery 1037 to MCU 1036 may be transmitted to receiver module 1047 , and may allow receiver module 1047 to optimize transmitted power to minimize thermal dissipation in circuitry for power recovery 1037 .
  • This signal may also be used by the receiver module 1047 to sense coupling strength and alignment of receiver module 1047 relative to telemetry module 1031 .
  • FIG. 11 illustrates one embodiment of a system 1100 that comprises an electrode grid 1130 , a telemetry module 1131 , and a receiver module 1147 .
  • electrode grid 1130 and telemetry module 1131 are implanted in a patient.
  • Electrode grid 1130 may be in electrical communication with telemetry module 1131 , which may include wireless data and power transmission systems.
  • Receiver module 1147 may inductively provide power via a coil and may receive a data signal transmitted by telemetry module 1131 .
  • the inductive power transfer between receiver module 1147 and telemetry module 1131 may be accomplished using Class E architecture.
  • system 1100 allows for the adjustment of the carrier used by the inductive power transfer system and for the adjustment of the transmitted power.
  • an infrared detector (not shown) may be located in the center of receiver module 1147 .
  • An infrared-transparent window may be aligned over the infrared detector to provide a light path from an infrared transmitter (not shown) emitter in telemetry module 1131 .
  • a coil for inductive power transfer may be constructed by winding Litz wire around a soft substructure, or the RF coil may be integrated into a flexible receiver printed circuit board.
  • Receiver module 1147 may be fixed to the body by adhesives, compression bands, bandages, or any other methods.
  • an alignment indicator 1152 may be disposed on the receiver module 1147 .
  • Alignment indicator 1152 may provide an indication of the relative strength of the telemetry coupling between receiver module 1147 and telemetry module 1131 .
  • Alignment indicator 1152 may allow a clinician to find the optimal placement for the receiver module 1147 .
  • Certain embodiments may be able to tolerate alignment errors up to 1 cm from center.
  • Receiver module 1147 may be coupled to a power source and a neural instrumentation system by way of wire 1154 . Certain embodiments may feature an interface adapter for connecting the External Transceiver to the GrapevineTM neural instrumentation system, which is available from Ripple, LLC of Salt Lake City, Utah. The GrapevineTM neural instrumentation system is available in both bedside and wearable configurations. The neural instrumentation system may provide for recording of data received by receiver module 1147 .
  • FIG. 12 illustrates an embodiment of a system 1200 that comprises a stimulating electrode array 1220 , stimulation leads 1221 , a recording electrode array 1230 , recording leads 1231 , and an electronics module 1240 .
  • all components are implanted subcutaneously in a patient.
  • the stimulation electrode array 1220 and stimulation leads 1221 may consist of a contiguous structure of layered conductive polymer and insulating substrate materials.
  • the recording electrode array 1230 and recording leads 1231 may also consist of a contiguous structure of layered conductive polymer and insulating substrate materials.
  • the stimulation 1220 and recording 1230 arrays are electrically connected to the electronics module 1240 via their respective leads 1221 and 1231 .
  • the electronics module 1240 communicates with an external module (not shown) in a manner similar to the telemetry protocol outlined between components 1131 and 1147 shown in FIG. 11 .
  • the stimulation lead 1221 may also include a mechanical feature 1222 designed to provide additional stress relief around the lateral canthus area to mitigate flexion forces.
  • the stimulation electrode array 1220 may also have a plurality of electrodes 1223 designed to permit the efficient conduction of exogenous charge to paretic and paralytic facial musculature.
  • This embodiment may be used as a blink prosthesis to restore eyelid function to patients with unilateral facial paralysis.
  • the exogenous electrical charge it injects may functionally activate paretic or paralytic muscles to effect closure of the lid margin.
  • the prosthesis records EMG with an array 1230 implanted in the contralateral neurologically intact hemiface to detect the onset of blink, and uses this detected signal to time stimulation via the implanted electrode array 1220 in the nonfunctioning eyelid to create a synchronous bilateral blink. Stimulation may also provide a trophic effect to permit more complete and more rapid recovery in facial paralysis patients.
  • FIG. 13 illustrates one embodiment of a method 1300 for manufacturing an electrode array and an associated telemetry module. Also shown in FIG. 13 is an illustration of each step of method 1300 .
  • the electrode array comprises medical grade polymers, with insulating polymer forming the main body and a conductive, particle-filled polymer of similar formulation providing the conductive traces and active electrode sites.
  • the electrode array may be formed with blunt and/or soft edges that allow pushing into spaces while minimizing the changes of cutting and/or rupturing vasculature and other sensitive tissues (for example, minimizing chances of cutting blood vessels within subdural and epidural spaces in the head).
  • the electrode array and associated telemetry module may be created in a layer-by-layer buildup of materials, with the conductive traces disposed between insulating layers.
  • Each layer of the device may be deposited in a variety of ways, such as by a programmable XYZ robotic dispensing system.
  • a mold may be prepared.
  • the mold may take on a variety of shapes, as dictated by the particular application for which the device is to be utilized.
  • the mold may be fabricated from a variety of materials, such as fluoropolymers. Alternatively, a flat plate may be used instead of a mold.
  • the base layer of insulating polymer may be dispensed in the desired pattern and each subsequent layer following a similar pattern. Surface tension of the dispensed material may be sufficient to produce a fabricated device in a desired shape.
  • the shape of an electrode array may be adjusted at the time of implantation. For example, a surgeon may trim the electrode array in order to suit a particular application.
  • a base layer of insulating polymer (e.g., silicone) may be dispensed into the prepared mold, at 1304 .
  • a printed circuit board (PCB) with electronic components may be pressed into a well in the mold using an alignment fixture, level with the surrounding substrate layer at 1306 . Further, at 1306 , conductive polymer traces and electrode interfaces may be printed.
  • a second layer of insulating polymer may be printed. The second layer of insulating polymer may be applied over the signal traces and around the electrode interfaces. Partial curing and plasma surface treatments may be used between deposition steps to enhance bonding.
  • pre-cure viscosity pre-cure viscosity
  • surface tension for dispensing without the aid of a mold curing properties
  • post-cure rigidity adhesion between layers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Radiology & Medical Imaging (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Manufacturing & Machinery (AREA)
  • Microelectronics & Electronic Packaging (AREA)
  • Cardiology (AREA)
  • Electrotherapy Devices (AREA)
  • Neurology (AREA)

Abstract

Disclosed herein are systems and methods for producing and using electrodes, which may be flexible and/or stretchable, and interconnection structures that can be used both externally and/or implanted within the body. Electrodes according to various embodiments disclosed herein may be produced by depositing patterned layers of insulating and conductive polymers to form multi-layer circuits. The conductive materials and layers in the structure can be exposed on the surface of the structures for use as electrodes. A plurality of electrodes may be formed into an electrode array. In various embodiments, electrode arrays may be associated with telemetry modules configured to wirelessly transmit data collected by the electrode array to a receiver module.

Description

    RELATED APPLICATIONS
  • This application is a continuation of patent application Ser. No. 12/889,310, filed on Sep. 23, 2010 and titled “SYSTEMS AND METHODS FOR FLEXIBLE ELECTRODES,” which application claims the benefit under 35 U.S.C. §119(e) of U.S. Provisional Patent Application No. 61/245,276, filed Sep. 23, 2009, titled “Thin Film Electrode and Interconnect Technology with Optional Integrated Electronics.” The entire contents of both of the foregoing applications are incorporated herein by reference.
  • FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT
  • This invention was made with U.S. Government support under contract no.: R44NS061604 awarded by National Institutes of Health. The U.S. Government has certain rights in this invention.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 illustrates a cross-sectional view of one embodiment of an electrode.
  • FIG. 2 illustrates a top view of one embodiment of an electrode.
  • FIGS. 3A, 3B, and 3C are cross sectional views that illustrate three embodiments of electrodes.
  • FIG. 4A illustrates a cross sectional view of one embodiment of an electrode comprising two electrode interfaces.
  • FIG. 4B illustrates a cross sectional view of an electrode that includes a connector in electrical communication with an electrode interface.
  • FIG. 5 illustrates a cross sectional view of one embodiment of an electrode that includes an electronic package.
  • FIG. 6 illustrates a side view of one embodiment of an electrode that includes a printed circuit board, which is coupled to an optical transceiver and an application specific integrated circuit.
  • FIG. 7 illustrates a cross sectional view of one embodiment of a multi-layer electrode.
  • FIG. 8 illustrates a cross-sectional view of one embodiment of a multi-layer electrode and a connector.
  • FIG. 9 illustrates one embodiment of an electrode array.
  • FIG. 10A illustrates a block diagram of one embodiment of an implantable system that includes an electrode grid and a signal processing unit.
  • FIG. 10B illustrates a block diagram of one embodiment of a wireless system that includes an electrode grid, a telemetry module, and a receiver module.
  • FIG. 11 illustrates one embodiment of a system that comprises an electrode grid, a telemetry module, and a receiver module.
  • FIG. 12 illustrates one embodiment which includes components for electrical stimulation and/or recording as part of a biocompatible system.
  • FIG. 13 illustrates one embodiment of a method for manufacturing an electrode array and an associated telemetry module.
  • DETAILED DESCRIPTION OF PREFERRED EMBODIMENTS
  • Disclosed herein are systems and methods for producing and using electrodes, which may be flexible and/or stretchable, and interconnection structures that can be used both externally and/or implanted within the body. Electrodes according to various embodiments disclosed herein may be produced by depositing patterned layers of insulating and conductive polymers to form multi-layer circuits. The conductive materials and layers in the structure can be exposed on the surface of the structures for use as electrodes. A plurality of electrodes may be formed into an electrode array. In various embodiments, electrode arrays may be associated with telemetry modules configured to wirelessly exchange data between an implantable component and an external module.
  • Certain embodiments may be suited for short-term implantation, while other embodiments may be suited for long-term implantation. Still other embodiments may be used for in vitro applications. Some applications of the systems and methods disclosed herein may include recording from and stimulation of neural tissue, stimulation of muscles, sub- and epi-dural monitoring, use in connection with a blink prosthesis, use in treating incontinence via posterior tibial nerve stimulation, use in restoring sexual function via stimulation of the spinal cord, use in recording implanted EMG and neural signals for use in prosthesis control, use in the stimulation of the recurrent laryngeal nerve for treatment of dystonia, use in stimulation of peripheral nerves for nerve block, and use in connection with neuroprosthetic and neural interface applications (e.g., a pacemaker device).
  • Multiple types of conductive polymers can be used within the same structure depending on factors, such as cost, conductivity, biocompatibility, and manufacturability for different feature sizes. For example, exposed electrode areas can also be formed from a conductive polymer that is different from conductive polymers used within the structures.
  • According to various embodiments, electrodes on the surface of the structure can also be formed by embedding metal or other electrode materials into the structures, and connecting to them with conductive polymers. These electrodes may also include geometrical and structural features for penetrating into tissues, hooking or providing mechanical fixation, mitigating stress around flexion points, or increasing the surface area of the electrode. In some embodiments, conducting traces can also be brought to the surface of the structure to create contact pads for bonding to other devices, including sensors, actuators, or other devices or assemblies. Bonding can be performed by applying pressure to hold the conductive areas in contact with bond pads on the devices, or by applying conductive adhesives or joining materials. These joints can also be further encapsulated with insulating polymers, such as silicones to seal and/or structurally reinforce them.
  • In various embodiments, electrodes may include embedded electronics. Such electronics may include, but are not limited to, any combination of silicon integrated circuits (“ICs”), circuit boards with electronic components, hermetic enclosures with contacts and feed-throughs to internal electronics, and the like. These electronics may include amplifiers, filters, analog to digital conversion, digital signal processing, stimulators, control circuits, fail-safe monitoring, data error checking, batteries, and connections for data and power telemetry with external devices.
  • Flexible electrodes, according to the present disclosure, may be manufactured by any method for controlled dispensing and/or forming of insulating and conductive polymers into patterns, including: spraying polymer layers onto a surface; depositing polymer layers through needles and narrow dispensing nozzles, including those that use gas pressure and positive displacement for flow control; depositing polymer layers through an ink jet dispenser (such as picodot systems); depositing polymer layers by screen printing and printing through masks; using optical, plasma, or chemical methods to selectively activate areas of a substrate to facilitate selective coating of areas with patterns of polymers; using laser ablation, or plasma or chemical etching (including use of photolithography or overlay masks) to selectively remove and form patterns in layers of deposited polymers; and depositing polymer layers onto both 2D surfaces and 3D molds.
  • Applications for electrodes, as disclosed herein, may include any application for which electrodes are currently utilized. Certain embodiments may be employed for sensing of electrophysiological signals from cells, tissues, organs, and body parts, including signals from nerves and muscles, EEG, EMG, ECG, EOG, ERG, ENG, ECoG, EGG, LFP, single and multiunit action potentials, and evoked potentials. Sensing and recording can be performed at the cell, tissue, organ, and body part scales, and used for diagnostic purposes, construction of neuroprosthetic systems for functional restoration, and brain machine interfaces to control external devices based on neural and/or muscle signals. These devices can be used for implanted and external body surface applications, as well as for temporary insertion into and/or application to tissues and organs during surgery and diagnostic procedures, for both short- and long-term sensing purposes.
  • In addition, various embodiments disclosed herein may be utilized for electrical stimulation of cells, tissues, organs, and body parts, including stimulation of nerves and muscles, for diagnostic purposes, enhancing trophic effects, functional restoration or rehabilitation in Functional Electrical Stimulation (FES) and other neuroprosthesis systems, and neuromodulation applications including Deep Brain Stimulation (DBS) targets, the cerebral cortex, sympathetic and parasympathetic nerves, peripheral nerves, and the spinal cord. These devices can be used for implanted and external body surface applications, as well as for temporary insertion into and/or application to tissues and organs during surgery and diagnostic procedures, for both short- and long-term stimulation purposes.
  • Still other embodiments may be utilized for sensing potentials and currents related to chemical reactions associated with the electrodes, including reactions for oxygen sensing, pH sensing, protein-specific binding of materials to the electrodes, and other chemical sensors based on electrodes. These may also include chemical modification and/or coating of the electrodes, or use of the electrodes with other application-specific materials necessary to sense these reactions.
  • Flexible electrodes, as disclosed herein, may be also utilized for control or forcing chemical reactions associated with the electrodes, including release of chemicals or drugs, modification of the local chemical environment, and forcing of chemical reactions. These may also include chemical modification and/or coating of the electrodes, or use of the electrodes with other application-specific materials necessary to create or control these reactions. Various embodiments may also be utilized to control chemical reactions, such as gas evolution or pH changes to effect structural changes in materials, including inflation of balloons and changing the shape, rigidity and forces within the device.
  • Various embodiments disclosed herein may be utilized to generate and sense electrical currents in the body for device operation, implant integrity, and diagnostic and therapeutic use, including imaging and facilitation of trophic effects and promoting recovery and healing of tissues in the body, including nerves or bone, and restoring function to paralytic and paretic body parts. Measurements of electrode and biological material impedances may be collected, including fixed frequency impedance and multi-frequency impedance spectroscopy methods to characterize electrode interfaces and characteristics of cells, tissues, organs, and body parts of humans and animals, including nerve, muscle and dental tissues. Such measurements may include frequency, phase, and all other measures used to characterize impedances.
  • Still other uses of flexible electrodes, as disclosed herein, may include measurements of biological material impedances, which may used to compute impedance tomography images at the cell, tissue, organ, and body scale; application of potentials for electrophoresis, microelectrode array dish, and other in vitro applications; application of potentials for electroporation and other electrical modifications of tissues; and creation of voltage gradients to accelerate the delivery or migration of drugs.
  • Various techniques may be utilized in order to facilitate bonding and/or integration of a flexible electrode into a body. For example, adhesives may be applied to the structures to bond them to the body; coatings, such as hydrogels, PEG structures, or other biomaterials, may be used to modulate the tissue response to the structure, including coatings that release drugs for this purpose; coatings may be applied to the electrode to change the adhesion of body tissues to the structures; drugs may be embedded within the non-conducting or insulating material that are released over time to affect the biocompatibility and local tissue response to the implanted structures; chemical surface modification (e.g., hydrophobic, hydrophilic, or non-stick materials) may be utilized to affect the interaction of the surfaces with materials in the environment or biocompatibility in the body; nanomaterials or coatings (e.g., iridium, conductive polymers, or carbon nano-tubes) may be applied to electrodes to affect their biocompatibility and impedance; radio-opaque alignment markings, identification information, and/or serial numbers may be embedded into the structures for visualization under x-ray; shapes such as protuberances, pits, holes, or other features may be used to increase the surface area of the electrodes; barbs or hooking features may be included to fix the device within the body; flat tabs, strings, loops or other features may be used to grip, glue, and/or suture the electrode for fixation within the body; or a fabric mesh (such as Dacron) may be used for suturing and/or forming strong tissue adhesions to portions of the structure;
  • Flexible electrodes disclosed herein may be implanted into the body with a variety of methods, including: insertion into epidural and subdural spaces through openings in the cranium; folding/unfolding and/or rolling/unrolling to deploy the structure once inside the body; use of saline and/or air balloons within the structure to affect mechanical changes inside the body for fixation, application of pressure, guidance, manipulation of placement, or other purpose; use of guide needles and other surgical instruments to create pilot holes and channels for insertion of the structures into the tissue; and use of needles or other surgical instruments to push or pull the structures into the tissue, then removing the instruments while leaving the structures in place.
  • According to various embodiments, insulated conductors may be disposed within a flexible electrode. Providing insulated conductors within the flexible electrode may also allow for the connection of embedded electrodes; the connection of probes and sensors (e.g., accelerometers, pressure sensors, optical and IR sensors, contact switches, magnetic field sensors, capacitive sensors, inductive coils, thermal flux sensors, temperature sensors, proximity sensors, piezo sensors, ultrasound transducers, sound sensors, etc.); the connection of actuators or devices (e.g., force generators, motors, piezo actuators, electromagnets, coils, inductors, ultrasound transducers, stimulators, light emitting diodes etc.); the formation of flexible elastic resistor and capacitor elements that can stretch around tissues and detect structural changes in the sensor by changes in electrical impedance in the sensor elements; the formation of capacitive shields and guard traces for protection of other traces within the structure from interference and electrostatic discharge (ESD); and the measurement of conductivity within the electrode and electrode structures to diagnose problems within the device structure.
  • FIG. 1 illustrates a cross-sectional view of one embodiment of an electrode 100, according to the present disclosure. Electrode 100 includes an internal conductive polymer trace 104 that is disposed within an insulating polymer 106. An electrode interface 102 may be in electrical communication with internal conductive polymer trace 104. Internal conductive polymer trace 104 may also be in electrical communication with a connector 108. According to various embodiments, connector 108 may comprise a percutaneous or transcutaneous connector.
  • Insulating polymer 106 may comprise any flexible and/or elastomeric material that provides electrical insulation. According to various embodiments, insulating polymer 106 may comprise any combination of silicones, siloxanes, polydimethylsiloxane (PDMS), rubber materials, latex materials, polyesters, polypropylenes, polytetrafluoroethylenes (PTFE), Parylenes, liquid crystal polymers, polyimides, polyesterimides, polyamides, polybutyldienes (PBD), flexible copolymers, or any other polymer used for medical applications.
  • Internal conductive polymer trace 104 may comprise polymers that are intrinsically conductive (including polypyrrole, polyacetylene, polyaniline or poly[dioctyl-bithiophene] (PDOT)), or polymers that are doped with conductive particles. Any type of conductive particle may be utilized in connection with internal conductive polymer trace 104, including any combination of: conductive forms of carbon (including graphite, carbon black, vitreous carbon, acetyl carbon, and carbon nantotubes); metal particles (e.g., particles of silver, gold, platinum, iridium, platinum-iridium alloys, titanium, tungsten, stainless steel); particles of other materials (e.g., nickel, ceramics, or carbon) that are coated with metals with higher contact conductivity (e.g., silver, gold, iridium, and platinum). Further, according to various embodiments, particles of shapes and morphologies may be utilized to better facilitate electrical contact between conductive particles in the polymer. According to various embodiments utilizing polymers doped with conductive particles, conductive particles may be pre-mixed into the polymer that is subsequently formed into an electrode, may be simultaneously mixed with a polymer and dispensed to form an electrode, or may be injected into a previously dispensed polymer layer with a carrier material (e.g., toluene or alcohol).
  • According to various embodiments, the design and manufacturing of the flexible devices may also include: use of polymers that are made conductive by filling with conductive particles, and in which the polymer shrinks to keep conductive particles in compression; polymers that shrink, expand, and/or soften after curing or when exposed to the body, to introduce stresses and/or shape changes into the material and/or other changes in mechanical compliance; substrate layers that are stretched during application of other layers, to keep the secondary layers in compression when the substrate is relaxed; other materials and fibers (including carbon or glass fibers) embedded into the structures to provide mechanical strain reinforcement and/or affect the mechanical properties of the structure in homogeneous and complex heterogeneous arrangements; coatings (such as polyethylene glycol) that stiffen the structure to aid insertion into tissues, that soften or dissolve away over time; formation of twisted-pair cables and/or cable ground planes within the structure; use of magnetic fields to manipulate conductive polymers with particles that respond to magnetic fields; plasma cleaning or other types of surface activation and adhesion promotion methods (such as silanes or other compounds) applied to polymer layers to enhance their bonding and reduce the chances of delamination.
  • FIG. 2 illustrates a top view of one embodiment of an electrode 200 according to the present disclosure. Electrode 200 includes a plurality of internal conductive polymer traces 204 a-d surrounded by an insulating polymer 206. A plurality of electrode interfaces 202 a-d power in electrical communication with internal conductive polymer traces 204 a-d, respectively. Although FIG. 2 illustrates an embodiment including four electrode interfaces 202 a-d associated with four internal conductive polymer traces 204 a-d, according to various embodiments, any number of electrode interfaces 202 may be utilized in connection with any number of internal conductive polymer traces 204. Internal conductive polymer traces 204 a-d are also in electrical communication with connector 208.
  • Multiple types of conductive polymers can be used within the same structure, depending on factors such as cost, conductivity, biocompatibility, and manufacturability for different feature sizes. FIGS. 3A-3C are cross sectional views that illustrate three embodiments of electrodes 300 a-c, which may be utilized in various embodiments. FIG. 3A illustrates electrode 300 a, in which the same material forms both an internal conductive polymer trace 304 a and an electrode interface 302 a. An insulating polymer 306 a is disposed around electrode interface 302 a and internal conductive polymer trace 304 a. FIG. 3B illustrates electrode 300 b, in which an internal conductive polymer trace 304 b comprises one polymer, and an electrode interface 302 b comprises a second polymer. An insulating polymer 306 b is disposed around electrode interface 302 b and internal conductive polymer trace 304 b. FIG. 3C illustrates electrode 300 c, in which an electrode interface 302 c is comprised of metal. Electrode interface 302 c is in electrical communication with an internal conductive polymer trace 304 c. An insulating polymer 306 c is disposed around electrode interface 302 c and internal conductive polymer trace 304 c.
  • Electrode interfaces 302 a-c may, in various embodiments, include geometrical and structural features for penetrating into tissues, hooking or providing mechanical fixation, or increasing the surface area of the electrode. Bonding between electrode interfaces 302 b-c and internal conductive polymer traces 304 b-c can be performed by the application of pressure to hold the conductive areas in contact, or by applying conductive adhesives or joining materials. These joints can also be further encapsulated with insulating polymers such as silicones to seal and/or structurally reinforce them.
  • FIG. 4A illustrates a cross sectional view of one embodiment of an electrode 400 comprising two electrode interfaces 402 and 403. Electrode interfaces 402 and 403 are in electrical communication by way of internal conductive polymer trace 404. Electrode interfaces 402 and 403 and internal conductive polymer trace 404 are surrounded by insulating polymer 406. Embodiments including multiple electrode interfaces, such as electrode 400, may allow for the connection of other devices, including sensors, actuators, or other devices or assemblies to electrode 400.
  • FIG. 4B illustrates a cross sectional view of electrode 400 that also includes a connector 408 in electrical communication with electrode interface 403. Various embodiments may also include connectors, including percutaneous connectors that pass out of the body. Such connectors may, in various embodiments, be encased in titanium, sintered titanium, stainless steel, polymer fabrics, or other materials to facilitate better biocompatibility and infection resistance for percutaneous applications. These connectors may also include screw holes, mounting flanges, rings, loops, fasteners, fabrics, or other structures for fixing the connector to tissue, skin, and/or bone.
  • FIG. 5 illustrates a cross sectional view of one embodiment of an electrode 500 that includes a printed circuit board 510 and various electronic components 512, 514, and 516. Electrode 500 also includes an electrode interface 502 in electrical communication with an internal conductive polymer trace 504. An insulating polymer 506 may be disposed around internal conductive polymer trace 504, printed circuit board 510, and various electronic components 512, 514, and 516. According to various embodiments, a variety of electronic components may be integrated with a printed circuit board 510. For example, such electronic components may include amplifiers, stimulators, data transmission circuitry, light emitting diodes and/or photo sensing diodes, data processing circuitry, batteries, and/or circuitry for receiving power from an external power source.
  • FIG. 6 illustrates a side view of an electrode 600 that includes a printed circuit board 610, which is coupled to a transceiver 620, and an application specific integrated circuit 618. An insulating polymer 606 may be disposed around an internal conductive polymer trace 604, printed circuit board 610, application specific integrated circuit 618, and transceiver 620. Wire leads 622 may electrically connect a printed circuit board 610 to application specific integrated circuit 618.
  • Certain embodiments may utilize infrared data transmission in order to transmit data collected by electrode 600 to an external data receiver (not shown). Such embodiments may comprise materials with optical properties selected for selective transparency to certain optical or infrared signals so that the device can use these wavelengths for telemetry. For example, insulating polymer 606 may be selected so as to provide minimal attenuation to an infrared data signal generated by transceiver 620.
  • FIG. 7 illustrates a cross sectional view of one embodiment of a multi-layer electrode 700. Electrode 700 comprises a plurality of internal conductive polymer traces 706 a-d separated by a plurality of insulating layers 704 a-d. Electrode 700 includes conductive vias 722, 724, 726, 728, and 730 that connect between internal conductive polymer traces 706 a-d and/or the surface of electrode 700. Electrode 700 includes through via 722, which passes through all conductive layers to the surface of electrode 700; blind vias 726, 728, and 730, which pass from the surface of electrode 700 to some conductive layers; and buried vias 724 and 725, which are completely embedded within electrode 700.
  • FIG. 8 illustrates a cross-sectional view of one embodiment of a multi-layer electrode 800 and a connector 808. Connector 808 may comprise a plurality of penetrating electrodes 809, which although not shown in a grid configuration in FIG. 8, may be arranged in a grid configuration. A plurality of internal conductive polymer traces 806 a-h may be in electrical communication with the plurality of penetrating electrodes 809. A plurality of insulating polymer layers 804 a-g may be disposed between the plurality of internal conductive polymer traces 806 a-h. Accordingly, electrical signals may be confined to internal conductive polymer traces 806, which may in turn be transmitted to an external connector.
  • FIG. 9 illustrates one embodiment of an electrode array 900. Electrode array 900 may include an electrode grid 930 that includes a plurality of individual electrodes. Although FIG. 9 illustrates a square electrode array 900, having eight electrodes on each side, any number of configurations may also be utilized in alternative embodiments. Each electrode in electrode grid 930 may be in electrical communication with an internal conductive polymer trace (not shown). A plurality of internal conductive polymer traces may be grouped in one of a plurality of lead wires 932. Lead wires 932 may also be an electrical communication with the plurality of leads 934. Electrical signals received by each of the plurality of electrodes in electrode grid 930 may be conducted to one of the plurality of leads 934.
  • In one embodiment, electrode array 900 may be utilized for intracranial epilepsy monitoring. Some of the patients suffering from epilepsy that do not respond adequately to drug therapies are candidates for surgical treatment to resect or disrupt seizure foci. In preparation for such a surgery, an electrode array, such as electrode array 900, may be implanted over the focal areas for up to 30 days to accurately localize the seizure foci and minimize damage to surrounding cortical areas. According to various embodiments, electrode arrays may range in size from large grids (e.g., 9 cm×9 cm) to small strips of electrodes (e.g., 1 cm×6 cm). Additional embodiments include high density microECoG electrodes which may be present in conjunction with larger conventional cortical mapping electrodes. After implantation, lead wires 932 may connect the implanted electrode array to a neural instrumentation system (not shown), which records information regarding electrical conditions detected by the plurality of electrodes in electrode grid 930. Lead wires 932 may pass through the scalp of the patient. The use of percutaneous lead wires 932 may expose patients to a risk of infection.
  • FIG. 10A illustrates a block diagram on one embodiment of an implantable system 1000A that includes an electrode grid 1030 and a signal processing unit 1034. According to various embodiments, system 1000A may be utilized in a variety of applications, including deep brain stimulation and intracranial monitoring. Electrode grid 1030 is in electrical communication with signal processing unit 1034 and may exchange data with signal processing unit 1034. Data may be received by signal processing unit 1034 and recorded and/or data may be transmitted from signal processing unit 1032 to electrode grid 1030 in order to provide electrical stimulation. Data sent to or received from electrode grid 1034 may be conditioned by signal conditioner 1034. Such conditioning may include, in various embodiments, amplification, analog to digital conversion (e.g., conversion of analog data recorded by electrode grid 1030 to digital data), and digital to analog conversion (e.g., conversion of digital data from signal processing unit 1032 to analog data). A microprocessor unit (“MCU”) 1036 may be in electrical communication with signal conditioner 1034, and may record, analyze, and/or generate data signals received from work to be sent to electrode grid 1030. A battery 1037 may provide power to MCU 1036 and signal conditioner 1034.
  • FIG. 10B illustrates a block diagram of one embodiment of a wireless system 1000B that includes an electrode grid 1030, a telemetry module 1031, and a receiver module 1047. In various embodiments, system 1000 may be utilized for intracranial epilepsy monitoring. Telemetry module 1031 and receiver module 1047 may be configured to exchange data and power wirelessly across the patient's skin 1051. In contrast to the embodiment illustrated in FIG. 9, system 1000 does not include percutaneous lead wires, and accordingly, use of system 1000 may reduce the risk of infection to a patient associated with percutaneous lead wires.
  • The electrode grid 1030 is in electrical communication with a telemetry module 1031. Telemetry module 1031 includes an amplifier 1033, which receives and amplifies signals collected by each of the plurality of individual electrodes. Amplifier 1033, in one particular embodiment, may comprise analog amplifier components, such as those available from Intan, Technologies, LLC of Salt Lake City, Utah. Amplified signals generated by amplifier 1033 may be converted to digital signals by ND converter 1035. According to various embodiments, A/D converter 1035 may also comprise a multiplexer configured to generate a digital output from a plurality of analog inputs.
  • A microprocessor unit (MCU) 1036 may receive and process the output of A/D converter 1035. According to various embodiments, MCU 1036 may comprise a commercially available microcontroller, or may comprise an application specific integrated circuit. In one particular embodiment, MCU 1036 may be embodied as a microprocessor in the TI MSP430 product family available from Texas Instruments of Dallas, Tex. In various embodiments, MCU 1036 may comprise both one-time programmable memory for core software storage and EEPROM memory for device serialization information and special feature programming.
  • MCU 1036 may prepare data to be transmitted by a data transceiver 1048. In one embodiment data transceiver 1048 may comprise an infrared transceiver, and infrared data may be transmitted via a Return to Zero (RZ) scheme with adaptive thresholding. If further DC balance is needed, 86106 or Manchester codes may be utilized. All data may include error-checking codes. In an alternative embodiment, data transceiver 1048 may comprise a radio frequency data transmission system.
  • System 1000 may also include a receiver module 1047, which may be separated from telemetry module 1031 by the skin 1051 of the patient. Receiver module 1047 may comprise a data transceiver 1042. Receiver module 1047 and telemetry module 1031 may exchange data across the patient's skin using a bidirectional communications channel. Data received from telemetry module 1031 may include recorded data from electrode grid 1030, while data transmitted to telemetry module 1031 may comprise data to provide stimulation using electrode grid 1030.
  • Receiver module 1042 may further comprise a power transmitter 1046, which is coupled to a coil 1044. Coil 1044 may be inductively coupled to coil 1040. Power transferred to coil 1040 may be provided to a circuit for power recovery 1037, which may in turn provide power to A/D converter 1035 and amplifier 1033. According to various embodiments, inductive coupling between coil 1044 and coil 1040 may also be used to transmit data. Circuitry for power recovery circuit 1037 may comprise a resonant full-wave rectifier (not shown) and filter with a low drop-out linear regulator (not shown). Circuitry for power recovery 1037 may also include the ability to measure the over-voltage of the rectifier and pass the signal to MCU 1036 for sampling. This signal passed from circuitry for power recovery 1037 to MCU 1036 may be transmitted to receiver module 1047, and may allow receiver module 1047 to optimize transmitted power to minimize thermal dissipation in circuitry for power recovery 1037. This signal may also be used by the receiver module 1047 to sense coupling strength and alignment of receiver module 1047 relative to telemetry module 1031.
  • FIG. 11 illustrates one embodiment of a system 1100 that comprises an electrode grid 1130, a telemetry module 1131, and a receiver module 1147. In the illustrated embodiment, electrode grid 1130 and telemetry module 1131 are implanted in a patient. Electrode grid 1130 may be in electrical communication with telemetry module 1131, which may include wireless data and power transmission systems.
  • Receiver module 1147 may inductively provide power via a coil and may receive a data signal transmitted by telemetry module 1131. The inductive power transfer between receiver module 1147 and telemetry module 1131 may be accomplished using Class E architecture. In various embodiments, system 1100 allows for the adjustment of the carrier used by the inductive power transfer system and for the adjustment of the transmitted power. In one embodiment, an infrared detector (not shown) may be located in the center of receiver module 1147. An infrared-transparent window may be aligned over the infrared detector to provide a light path from an infrared transmitter (not shown) emitter in telemetry module 1131. In various embodiments, a coil for inductive power transfer may be constructed by winding Litz wire around a soft substructure, or the RF coil may be integrated into a flexible receiver printed circuit board. Receiver module 1147 may be fixed to the body by adhesives, compression bands, bandages, or any other methods.
  • In certain embodiments, an alignment indicator 1152 may be disposed on the receiver module 1147. Alignment indicator 1152 may provide an indication of the relative strength of the telemetry coupling between receiver module 1147 and telemetry module 1131. Alignment indicator 1152 may allow a clinician to find the optimal placement for the receiver module 1147. Certain embodiments may be able to tolerate alignment errors up to 1 cm from center.
  • Receiver module 1147 may be coupled to a power source and a neural instrumentation system by way of wire 1154. Certain embodiments may feature an interface adapter for connecting the External Transceiver to the Grapevine™ neural instrumentation system, which is available from Ripple, LLC of Salt Lake City, Utah. The Grapevine™ neural instrumentation system is available in both bedside and wearable configurations. The neural instrumentation system may provide for recording of data received by receiver module 1147.
  • FIG. 12 illustrates an embodiment of a system 1200 that comprises a stimulating electrode array 1220, stimulation leads 1221, a recording electrode array 1230, recording leads 1231, and an electronics module 1240. In the illustrated embodiment, all components are implanted subcutaneously in a patient. The stimulation electrode array 1220 and stimulation leads 1221 may consist of a contiguous structure of layered conductive polymer and insulating substrate materials. Similarly the recording electrode array 1230 and recording leads 1231 may also consist of a contiguous structure of layered conductive polymer and insulating substrate materials. The stimulation 1220 and recording 1230 arrays are electrically connected to the electronics module 1240 via their respective leads 1221 and 1231. The electronics module 1240 communicates with an external module (not shown) in a manner similar to the telemetry protocol outlined between components 1131 and 1147 shown in FIG. 11. The stimulation lead 1221 may also include a mechanical feature 1222 designed to provide additional stress relief around the lateral canthus area to mitigate flexion forces. The stimulation electrode array 1220 may also have a plurality of electrodes 1223 designed to permit the efficient conduction of exogenous charge to paretic and paralytic facial musculature.
  • This embodiment may be used as a blink prosthesis to restore eyelid function to patients with unilateral facial paralysis. The exogenous electrical charge it injects may functionally activate paretic or paralytic muscles to effect closure of the lid margin. The prosthesis records EMG with an array 1230 implanted in the contralateral neurologically intact hemiface to detect the onset of blink, and uses this detected signal to time stimulation via the implanted electrode array 1220 in the nonfunctioning eyelid to create a synchronous bilateral blink. Stimulation may also provide a trophic effect to permit more complete and more rapid recovery in facial paralysis patients.
  • FIG. 13 illustrates one embodiment of a method 1300 for manufacturing an electrode array and an associated telemetry module. Also shown in FIG. 13 is an illustration of each step of method 1300. In the illustrated embodiment, the electrode array comprises medical grade polymers, with insulating polymer forming the main body and a conductive, particle-filled polymer of similar formulation providing the conductive traces and active electrode sites. According to various embodiments, the electrode array may be formed with blunt and/or soft edges that allow pushing into spaces while minimizing the changes of cutting and/or rupturing vasculature and other sensitive tissues (for example, minimizing chances of cutting blood vessels within subdural and epidural spaces in the head). The electrode array and associated telemetry module may be created in a layer-by-layer buildup of materials, with the conductive traces disposed between insulating layers. Each layer of the device may be deposited in a variety of ways, such as by a programmable XYZ robotic dispensing system.
  • At 1302, a mold may be prepared. The mold may take on a variety of shapes, as dictated by the particular application for which the device is to be utilized. The mold may be fabricated from a variety of materials, such as fluoropolymers. Alternatively, a flat plate may be used instead of a mold. The base layer of insulating polymer may be dispensed in the desired pattern and each subsequent layer following a similar pattern. Surface tension of the dispensed material may be sufficient to produce a fabricated device in a desired shape. Further, the shape of an electrode array may be adjusted at the time of implantation. For example, a surgeon may trim the electrode array in order to suit a particular application.
  • A base layer of insulating polymer (e.g., silicone) may be dispensed into the prepared mold, at 1304. A printed circuit board (PCB) with electronic components may be pressed into a well in the mold using an alignment fixture, level with the surrounding substrate layer at 1306. Further, at 1306, conductive polymer traces and electrode interfaces may be printed. At 1308, a second layer of insulating polymer may be printed. The second layer of insulating polymer may be applied over the signal traces and around the electrode interfaces. Partial curing and plasma surface treatments may be used between deposition steps to enhance bonding.
  • The following criteria may be utilized in evaluating suitable materials for use in connection with method 1300: pre-cure viscosity; surface tension for dispensing without the aid of a mold; curing properties; post-cure rigidity; adhesion between layers; ability to act as a carrier for the conductive particles.
  • Commercially available medical grade conductive silicones may be utilized in connection with 1300, and are available from NuSil in Carpinteria, Calif., and Creative Materials in Tyngsboro, Mass.
  • It will be obvious to those having skill in the art that many changes may be made to the details of the above-described embodiments without departing from the underlying principles of the invention. The scope of the present invention should, therefore, be determined only by the following claims.

Claims (20)

1. A method of forming a flexible electrode, comprising:
depositing a first layer along a length of the flexible electrode, the first layer comprising a first polymer, the first polymer comprising an insulating polymer;
depositing a second layer on the first layer and along at least a portion of the length of the flexible electrode, the second layer comprising a second polymer and a conductive trace, the conductive trace comprising a plurality of distinct conductive particles, at least a plurality of the distinct conductive particles being separated by the second polymer;
forming an electrode interface in electrical communication with the conductive polymer trace; and
depositing a third layer, the third layer comprising the insulating polymer, such that the first layer and the third layer encompass the conductive trace along at least a portion of the length.
2. The method of claim 1, wherein each of the first layer, the second layer, and the third layer are directly deposited.
3. The method of claim 1, wherein each of the first layer, the second layer, and the third layer are deposited using an ink jet process.
4. The method of claim 1, wherein each of the first layer, the second layer, and the third layer are deposited using a screen printing process.
5. The method of claim 1, wherein each of the first layer, the second layer, and the third layer comprise a bio stable polymer.
6. The method of claim 1, wherein the plurality of distinct conductive particles comprises at least one of: conductive forms of carbon, metal particles, and composite materials comprising an interior particle coated with metal.
7. The method of claim 1, wherein the conductive trace comprises a plurality of distinct conductive micro-particles.
8. The method of claim 1, wherein the second layer exhibits a compressive force upon the plurality of distinct conductive particles.
9. The method of claim 1, wherein the second polymer comprises an intrinsically conductive polymer.
10. The method of claim 9, wherein the intrinsically conductive polymer comprises one of polypyrrole, polyacetylene, polyaniline, and polydioctyl-bithiophene.
11. The method of claim 1, further comprising associating a plurality of electrical components with the conductive trace.
12. The method of claim 11, further comprising:
providing a printed circuit board to interconnect the plurality of electrical components and the conductive trace; and
depositing the first layer and the third layer encompass the printed circuit board.
13. The method of claim 1, further comprising:
depositing a fourth layer, the fourth layer comprising a conductive trace, wherein the third layer at least partially insulates the third layer from the fourth layer along at least a portion of the length.
14. The method of claim 1, further comprising depositing at least one of the first layer, the second layer, and the third layer in a mold.
15. The method of claim 1, further comprising curing at least one of the first layer, the second layer, and the third layer.
16. The method of claim 1, further comprising:
generating an electrical signal using a stimulator in electrical communication with the conductive trace to be transmitted to the electrode interface.
17. A method of forming a flexible electrode, comprising:
depositing a first layer comprising an insulating polymer along a length of the flexible electrode;
depositing at least a second layer on the insulating polymer, the second layer comprising a second polymer, the second layer forming a plurality of conductive traces, each of the plurality of conductive traces comprising a plurality of distinct conductive particles, and each of the conductive traces being insulated from each of the other conductive traces by the insulating polymer;
forming a plurality of electrode interfaces, each of the plurality of electrode interfaces being in electrical communication with at least one of the plurality of conductive traces; and
depositing a third layer comprising the insulating polymer over the second layer, the third layer comprising the insulating polymer, such that the first layer and the third layer encompass the plurality of conductive traces along at least a portion of the length.
18. The method of claim 17, wherein at least one of the first layer, the second layer, and the third layer are formed using one of a direct deposition process, an ink jet process, a screen printing process.
19. The method of claim 17, further comprising depositing at least one of the first layer, the second layer, and the third layer in a mold.
20. The method of claim 17, wherein the plurality of electrode interfaces are disposed in a grid pattern.
US14/729,027 2009-09-23 2015-06-02 Systems and methods for flexible electrodes Abandoned US20150264816A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US14/729,027 US20150264816A1 (en) 2009-09-23 2015-06-02 Systems and methods for flexible electrodes

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24527609P 2009-09-23 2009-09-23
US12/889,310 US9061134B2 (en) 2009-09-23 2010-09-23 Systems and methods for flexible electrodes
US14/729,027 US20150264816A1 (en) 2009-09-23 2015-06-02 Systems and methods for flexible electrodes

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US12/889,310 Continuation US9061134B2 (en) 2009-09-23 2010-09-23 Systems and methods for flexible electrodes

Publications (1)

Publication Number Publication Date
US20150264816A1 true US20150264816A1 (en) 2015-09-17

Family

ID=44657213

Family Applications (2)

Application Number Title Priority Date Filing Date
US12/889,310 Active 2032-03-17 US9061134B2 (en) 2009-09-23 2010-09-23 Systems and methods for flexible electrodes
US14/729,027 Abandoned US20150264816A1 (en) 2009-09-23 2015-06-02 Systems and methods for flexible electrodes

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US12/889,310 Active 2032-03-17 US9061134B2 (en) 2009-09-23 2010-09-23 Systems and methods for flexible electrodes

Country Status (1)

Country Link
US (2) US9061134B2 (en)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9643022B2 (en) 2013-06-17 2017-05-09 Nyxoah SA Flexible control housing for disposable patch
US9849289B2 (en) 2009-10-20 2017-12-26 Nyxoah SA Device and method for snoring detection and control
US9855032B2 (en) 2012-07-26 2018-01-02 Nyxoah SA Transcutaneous power conveyance device
US9943686B2 (en) 2009-10-20 2018-04-17 Nyxoah SA Method and device for treating sleep apnea based on tongue movement
US10052097B2 (en) 2012-07-26 2018-08-21 Nyxoah SA Implant unit delivery tool
CN111134671A (en) * 2019-12-27 2020-05-12 上海交通大学 Flexible multi-channel repeatable array type HD-sEMG sensor and preparation
US10751537B2 (en) 2009-10-20 2020-08-25 Nyxoah SA Arced implant unit for modulation of nerves
US10814137B2 (en) 2012-07-26 2020-10-27 Nyxoah SA Transcutaneous power conveyance device
US11253712B2 (en) 2012-07-26 2022-02-22 Nyxoah SA Sleep disordered breathing treatment apparatus
US20230015298A1 (en) * 2021-07-13 2023-01-19 Biosense Webster (Isreal) Ltd. Ablation electrodes made from electrical traces of flexible printed circuit board

Families Citing this family (97)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8788042B2 (en) 2008-07-30 2014-07-22 Ecole Polytechnique Federale De Lausanne (Epfl) Apparatus and method for optimized stimulation of a neurological target
EP3231476B1 (en) 2008-11-12 2019-06-19 Ecole Polytechnique Fédérale de Lausanne Microfabricated neurostimulation device
KR101088806B1 (en) * 2009-01-07 2011-12-01 주식회사 뉴로바이오시스 Micro-electrode Array Package using Liquid Crystal Polymer and Manufacturing Method thereof
WO2011121089A1 (en) 2010-04-01 2011-10-06 Ecole Polytechnique Federale De Lausanne (Epfl) Device for interacting with neurological tissue and methods of making and using the same
FR2960787B1 (en) * 2010-06-09 2012-07-27 Commissariat Energie Atomique PROCESS FOR PRODUCING AN INTRAOCULAR RETINAL SOFT IMPLANT WITH DOPE DIAMOND ELECTRODES
EP2582289B1 (en) * 2010-06-15 2016-09-07 Ecole Polytechnique Fédérale de Lausanne (EPFL) Pdms-based stretchable multi-electrode and chemotrode array for epidural and subdural neuronal recording, electrical stimulation and drug delivery
WO2012094346A2 (en) 2011-01-03 2012-07-12 The Regents Of The University Of California High density epidural stimulation for facilitation of locomotion, posture, voluntary movement, and recovery of autonomic, sexual, vasomotor, and cognitive function after neurological injury
JP2014508581A (en) * 2011-01-21 2014-04-10 カリフォルニア インスティテュート オブ テクノロジー Parylene-based microelectrode array implant for spinal cord stimulation
WO2012129574A2 (en) 2011-03-24 2012-09-27 California Institute Of Technology Neurostimulator
WO2012158668A1 (en) * 2011-05-17 2012-11-22 Stryker Corporation Method of fabricating an implantable medical device that includes one or more thin film polymer support layers
US10092750B2 (en) 2011-11-11 2018-10-09 Neuroenabling Technologies, Inc. Transcutaneous neuromodulation system and methods of using same
BR112014011409A2 (en) 2011-11-11 2017-05-02 Neuroenabling Tech Inc noninvasive neuromodulation device to enable recovery of motor, sensory, autonomic, sexual, vasomotor and cognitive function
BR112014029065A2 (en) * 2012-05-25 2017-06-27 Koninklijke Philips Nv electrode patch for use in biopotential measurements in a magnetic resonance (rm) environment, biopotential measuring apparatus, and system
BR112014028810A2 (en) * 2012-05-25 2017-06-27 Koninklijke Philips Nv cable for use in biopotential measurements in a magnetic resonance (rm) environment, and biopotential measuring apparatus
DE102012013534B3 (en) 2012-07-05 2013-09-19 Tobias Sokolowski Apparatus for repetitive nerve stimulation for the degradation of adipose tissue by means of inductive magnetic fields
JP6424404B2 (en) * 2012-10-02 2018-11-21 国立研究開発法人科学技術振興機構 Signal detection apparatus and signal detection method
DE102012110358B4 (en) * 2012-10-30 2016-04-07 Leibniz-Institut für Neurobiologie Magdeburg Microelectrode array
US9026189B2 (en) * 2012-11-16 2015-05-05 Diopsys, Inc. Electrode sensor assembly for electroretinography and pattern electroretinography
EP4201469A1 (en) * 2012-12-05 2023-06-28 Battelle Memorial Institute Neuromuscular stimulation cuff
WO2014097450A1 (en) * 2012-12-20 2014-06-26 東北マイクロテック株式会社 Brain electrode system
WO2014165822A1 (en) * 2013-04-04 2014-10-09 The Arizona Board Of Regents On Behalf Of The University Of Arizona Materials, systems, devices, and methods for endoluminal electropolymeric paving and sealing
JP6212814B2 (en) * 2013-05-21 2017-10-18 国立研究開発法人科学技術振興機構 Multi-point probe, electronic contact sheet constituting the same, multi-point probe array, and method for manufacturing multi-point probe
US11229789B2 (en) 2013-05-30 2022-01-25 Neurostim Oab, Inc. Neuro activator with controller
CN105307719B (en) 2013-05-30 2018-05-29 格雷厄姆·H.·克雷西 Local nerve stimulation instrument
US20150217120A1 (en) 2014-01-13 2015-08-06 Mandheerej Nandra Neuromodulation systems and methods of using same
WO2015120190A1 (en) * 2014-02-05 2015-08-13 Ripple Llc Systems and methods for multi-layer electrodes
US11191471B2 (en) * 2014-02-27 2021-12-07 New York University Minimally invasive subgaleal extra-cranial electroencephalography (EEG) monitoring device
CN110585588A (en) 2014-05-16 2019-12-20 阿莱瓦神经治疗股份有限公司 Implantable microelectrode device
US11311718B2 (en) 2014-05-16 2022-04-26 Aleva Neurotherapeutics Sa Device for interacting with neurological tissue and methods of making and using the same
US9474894B2 (en) 2014-08-27 2016-10-25 Aleva Neurotherapeutics Deep brain stimulation lead
US10313027B2 (en) * 2014-09-11 2019-06-04 Koninklijke Philips N.V. Wide band through-body ultrasonic communication system
EP3205189A4 (en) 2014-10-08 2018-06-13 The Arizona Board of Regents on behalf of the University of Arizona Flowable electronics
US20160317057A1 (en) * 2014-10-22 2016-11-03 VivaLnk, Inc. Compliant wearable patch capable of measuring electrical signals
US9861289B2 (en) * 2014-10-22 2018-01-09 VivaLnk, Inc. Compliant wearable patch capable of measuring electrical signals
TWI696448B (en) 2014-11-11 2020-06-21 芬蘭商腦部關懷公司 An implantable electrode device and a method for manufacturing thereof
US11077301B2 (en) 2015-02-21 2021-08-03 NeurostimOAB, Inc. Topical nerve stimulator and sensor for bladder control
US20180093091A1 (en) * 2015-02-26 2018-04-05 Rb Patents Sarl Device for functional electrical stimulation and measurement of electromyogram, comprising means for short-circuiting and earthing a pair of electrodes, and associated transcutaneous electrode
US11491342B2 (en) 2015-07-01 2022-11-08 Btl Medical Solutions A.S. Magnetic stimulation methods and devices for therapeutic treatments
US10695575B1 (en) 2016-05-10 2020-06-30 Btl Medical Technologies S.R.O. Aesthetic method of biological structure treatment by magnetic field
US20180001107A1 (en) 2016-07-01 2018-01-04 Btl Holdings Limited Aesthetic method of biological structure treatment by magnetic field
US10172558B2 (en) * 2015-09-10 2019-01-08 University Of Utah Research Foundation Structure and methodology for a shadow mask having hollow high aspect ratio projections
US10155107B2 (en) 2015-10-07 2018-12-18 Medtronic, Inc. Implantable modular electrode array assembly
KR101635718B1 (en) * 2016-01-29 2016-07-01 김민기 Apparatus for hairdressing and beautycare using plasma
WO2017134587A1 (en) 2016-02-02 2017-08-10 Aleva Neurotherapeutics, Sa Treatment of autoimmune diseases with deep brain stimulation
WO2017139605A1 (en) * 2016-02-12 2017-08-17 Verily Life Sciences, LLC Systems and methods for coordinated neurostimulation with distributed micro particles
US11247039B2 (en) 2016-05-03 2022-02-15 Btl Healthcare Technologies A.S. Device including RF source of energy and vacuum system
US11464993B2 (en) 2016-05-03 2022-10-11 Btl Healthcare Technologies A.S. Device including RF source of energy and vacuum system
US11534619B2 (en) 2016-05-10 2022-12-27 Btl Medical Solutions A.S. Aesthetic method of biological structure treatment by magnetic field
US10583287B2 (en) 2016-05-23 2020-03-10 Btl Medical Technologies S.R.O. Systems and methods for tissue treatment
US20200138311A1 (en) * 2016-05-27 2020-05-07 Todoc Co., Ltd. Bio-Implantable Device and Method for Manufacturing Same
DE102016110137A1 (en) * 2016-06-01 2017-12-07 Medizinische Hochschule Hannover Shape-adaptive medical implant and use of an electrical signal source
JP6608340B2 (en) * 2016-06-29 2019-11-20 株式会社Anicall Belt cover
US10556122B1 (en) 2016-07-01 2020-02-11 Btl Medical Technologies S.R.O. Aesthetic method of biological structure treatment by magnetic field
US10207103B2 (en) 2016-07-05 2019-02-19 Pacesetter, Inc. Implantable thin film devices
US20180014783A1 (en) * 2016-07-13 2018-01-18 VivaLnk, Inc. Wearable patch having reliable conductive contacts for measuring electrical signals
KR101933032B1 (en) * 2016-09-07 2018-12-28 한국과학기술연구원 Carbon Nanotube-based CI Electrode Array
JP6832535B2 (en) * 2016-09-13 2021-02-24 国立大学法人大阪大学 Electrode sheet
FR3058310B1 (en) * 2016-11-09 2019-01-25 Arioneo CARDIO-FREQUENCEMETE ELECTRODE AND METHOD OF MEASURING HEART RATE
IT201700000165A1 (en) * 2017-01-02 2018-07-02 Spes Medica Srl Recording electrode and cortical stimulation and method of making this electrode
US10670429B2 (en) 2017-02-09 2020-06-02 The University Of British Columbia Capacitive bending sensors
US10831319B2 (en) 2017-02-09 2020-11-10 The University Of British Columbia Cluster sensor
US11376005B2 (en) * 2017-05-24 2022-07-05 University Of Florida Research Foundation, Incorporated Tissue-engineered electronic peripheral nerve interface
US11602630B2 (en) 2017-06-07 2023-03-14 Neuronexus Technologies, Inc. Systems and methods for flexible electrode arrays
GB2563386A (en) * 2017-06-08 2018-12-19 Creo Medical Ltd Electrosurgical instrument
DE20168827T1 (en) 2017-06-30 2021-01-21 Gtx Medical B.V. NEUROMODULATION SYSTEM
CN111093493A (en) 2017-10-06 2020-05-01 美敦力施美德公司 Absorbent cotton stimulation and recording electrode assembly
CN111601636A (en) 2017-11-07 2020-08-28 Oab神经电疗科技公司 Non-invasive neural activator with adaptive circuit
EP3720338A1 (en) 2017-12-05 2020-10-14 Ecole Polytechnique Federale de Lausanne (EPFL) A system for planning and/or providing neuromodulation
US10729564B2 (en) * 2018-01-12 2020-08-04 Ripple Llc Sensor system
US10729342B2 (en) 2018-02-28 2020-08-04 Medtronic Xomed, Inc. Nerve monitoring and/or stimulation electrode assemblies
US10702692B2 (en) 2018-03-02 2020-07-07 Aleva Neurotherapeutics Neurostimulation device
CN108606775A (en) * 2018-03-23 2018-10-02 天津大学 The preparation method in distributed flexible Bioelectronics and layer flexible channel
WO2020090157A1 (en) * 2018-11-02 2020-05-07 株式会社村田製作所 Flexible wiring board
EP3653256B1 (en) 2018-11-13 2022-03-30 ONWARD Medical N.V. Control system for movement reconstruction and/or restoration for a patient
EP3653260A1 (en) 2018-11-13 2020-05-20 GTX medical B.V. Sensor in clothing of limbs or footwear
CN113164201A (en) 2018-11-21 2021-07-23 伯恩森斯韦伯斯特(以色列)有限责任公司 Ablation catheter with stacked circuit components
EP3695878B1 (en) 2019-02-12 2023-04-19 ONWARD Medical N.V. A system for neuromodulation
CA3231026A1 (en) * 2019-03-11 2020-09-17 Benjamin I. Rapoport Endovascular electroencephalography (eeg) and electrocorticography (ecog) devices, systems and methods
US20220175320A1 (en) * 2019-03-22 2022-06-09 Verily Life Sciences Llc Thin-Film Lead Assemblies And Neural Interfaces
SI3721939T1 (en) 2019-04-11 2022-10-28 Btl Healthcare Technologies A.S. Device for aesthetic treatment of biological structures by radiofrequency and magnetic energy
WO2020232208A1 (en) * 2019-05-14 2020-11-19 Verily Life Sciences Llc Ophthalmic devices, systems and methods for treating dry eye
US11458311B2 (en) 2019-06-26 2022-10-04 Neurostim Technologies Llc Non-invasive nerve activator patch with adaptive circuit
US11444056B2 (en) * 2019-07-12 2022-09-13 Neuralink Corp. Sandwich assembly scheme for thin film electrode array and integrated circuits on both sides of printed circuit board (PCB) and method of manufacture
CN114641904A (en) 2019-10-10 2022-06-17 瑞普尔有限责任公司 System and method for coupling electrodes and electronic components
AU2020366623A1 (en) 2019-10-16 2022-04-07 Wyss Center For Bio And Neuro Engineering Optical transmission for an implantable system
DE19211698T1 (en) 2019-11-27 2021-09-02 Onward Medical B.V. Neuromodulation system
US20210169334A1 (en) * 2019-12-05 2021-06-10 Regents Of The University Of Minnesota Systems and methods for multimodal neural sensing
WO2021126921A1 (en) 2019-12-16 2021-06-24 Neurostim Solutions, Llc Non-invasive nerve activator with boosted charge delivery
US11878167B2 (en) 2020-05-04 2024-01-23 Btl Healthcare Technologies A.S. Device and method for unattended treatment of a patient
AU2021269187B2 (en) 2020-05-04 2023-02-23 Btl Healthcare Technologies A.S. Device and method for unattended treatment of a patient
JP7444821B2 (en) 2020-09-15 2024-03-06 信越化学工業株式会社 Bioelectrode composition, bioelectrode, bioelectrode manufacturing method, and silicon material particles
JP7444824B2 (en) 2020-09-24 2024-03-06 信越化学工業株式会社 Bioelectrode composition, bioelectrode, bioelectrode manufacturing method, and silicon material particles
US11896816B2 (en) 2021-11-03 2024-02-13 Btl Healthcare Technologies A.S. Device and method for unattended treatment of a patient
CN115054260A (en) * 2022-06-17 2022-09-16 中国科学院脑科学与智能技术卓越创新中心 Flexible electrode for spinal cord and manufacturing method thereof
WO2024009237A1 (en) * 2022-07-06 2024-01-11 Scuola Superiore Di Studi Universitari E Di Perfezionamento Sant'anna Neural electrode made with soft polymers and rapid prototyping techniques
WO2024040057A2 (en) * 2022-08-15 2024-02-22 EPIC Neuro, Inc. Neurostimulation systems and methods
WO2024119097A1 (en) * 2022-12-01 2024-06-06 Mayo Foundation For Medical Education And Research Brain implant devices and methods

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030228748A1 (en) * 2002-05-23 2003-12-11 Nelson Richard A. Circuit elements having an ink receptive coating and a conductive trace and methods of manufacture
US6829498B2 (en) * 2000-03-29 2004-12-07 Arizona Board Of Regents Device for creating a neural interface and method for making same

Family Cites Families (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4566464A (en) 1981-07-27 1986-01-28 Piccone Vincent A Implantable epilepsy monitor apparatus
US4735208B1 (en) 1987-01-09 1995-07-04 Ad Tech Medical Instr Corp Subdural strip electrode for determining epileptogenic foci
US4850359A (en) 1987-10-16 1989-07-25 Ad-Tech Medical Instrument Corporation Electrical brain-contact devices
US4903702A (en) 1988-10-17 1990-02-27 Ad-Tech Medical Instrument Corporation Brain-contact for sensing epileptogenic foci with improved accuracy
US5097835A (en) 1990-04-09 1992-03-24 Ad-Tech Medical Instrument Corporation Subdural electrode with improved lead connection
US5456254A (en) 1991-02-15 1995-10-10 Cardiac Pathways Corp Flexible strip assembly having insulating layer with conductive pads exposed through insulating layer and device utilizing the same
AU652494B2 (en) 1991-11-15 1994-08-25 Minnesota Mining And Manufacturing Company Solid state conductive polymer compositions, biomedical electrodes containing such compositions, and method of preparing same
US5279305A (en) 1992-08-06 1994-01-18 Pedifutures, Inc. Electroencephalograph incorporating at least one wireless link
US5400782A (en) 1992-10-07 1995-03-28 Graphic Controls Corporation Integral medical electrode including a fusible conductive substrate
SE502620C2 (en) 1993-02-26 1995-11-27 Leif Nilsson urinary catheter
US5433742A (en) 1993-11-19 1995-07-18 Willis; Allan Conductive adhesive band for cathether electrode
US5895369A (en) 1994-09-30 1999-04-20 Becton Dickinson And Company Iontophoresis patch/controller interconnection using a conductive elastomer to provide noise-free electrical contact between patch and controller
US5681514A (en) 1995-06-07 1997-10-28 Sulzer Intermedics Inc. Method for making an implantable conductive lead for use with a cardiac stimulator
US6480743B1 (en) 2000-04-05 2002-11-12 Neuropace, Inc. System and method for adaptive brain stimulation
US6095148A (en) 1995-11-03 2000-08-01 Children's Medical Center Corporation Neuronal stimulation using electrically conducting polymers
US5868136A (en) 1996-02-20 1999-02-09 Axelgaard Manufacturing Co. Ltd. Medical electrode
JP2000508825A (en) 1996-04-29 2000-07-11 ミネソタ マイニング アンド マニュファクチャリング カンパニー Conductors for biomedical electrodes and biomedical electrodes made therefrom
US5904712A (en) 1997-06-12 1999-05-18 Axelgaard Manufacturing Co., Ltd. Current-controlling electrode
US5843155A (en) 1997-06-12 1998-12-01 Axelgaard Manufacturing Company, Ltd. Current-controlling electrode system
US6024702A (en) 1997-09-03 2000-02-15 Pmt Corporation Implantable electrode manufactured with flexible printed circuit
US6259937B1 (en) 1997-09-12 2001-07-10 Alfred E. Mann Foundation Implantable substrate sensor
US6175752B1 (en) * 1998-04-30 2001-01-16 Therasense, Inc. Analyte monitoring device and methods of use
US6091979A (en) 1998-07-07 2000-07-18 Children's Medical Center Corporation Subdural electrode arrays for monitoring cortical electrical activity
US6048919A (en) 1999-01-29 2000-04-11 Chip Coolers, Inc. Thermally conductive composite material
US6304784B1 (en) 1999-06-15 2001-10-16 Arizona Board Of Regents, Acting For And On Behalf Of Arizona State University Flexible probing device and methods for manufacturing the same
US7346391B1 (en) 1999-10-12 2008-03-18 Flint Hills Scientific Llc Cerebral or organ interface system
US6973342B1 (en) 2000-03-02 2005-12-06 Advanced Neuromodulation Systems, Inc. Flexible bio-probe assembly
FI20001482A (en) 2000-06-21 2001-12-22 Instrumentarium Oyj Conductor
JP2004506530A (en) 2000-08-24 2004-03-04 ウィリアム・マーシュ・ライス・ユニバーシティ Polymer wrapped single-walled carbon nanotubes
US6862479B1 (en) 2000-08-30 2005-03-01 Advanced Bionics Corporation Spinal cord stimulation as a therapy for sexual dysfunction
US6624510B1 (en) 2000-09-28 2003-09-23 University Of Iowa Research Foundation Electrode array having a thin, flexible substrate
US6529774B1 (en) 2000-11-09 2003-03-04 Neuropace, Inc. Extradural leads, neurostimulator assemblies, and processes of using them for somatosensory and brain stimulation
DE60030170T2 (en) 2000-11-16 2007-08-23 Polyvalor, S.E.C., Montreal ELECTRONIC BODY IMPLANT AND SYSTEM FOR ARTIFICIAL SEEING
AU2002258637A1 (en) 2001-03-27 2002-10-08 Board Of Regents The University Of Texas System Biodegradable, electrically conductiong polymer for tissue engineering applications
US6643552B2 (en) 2001-05-30 2003-11-04 Foster-Miller, Inc. Implantable devices having a liquid crystal polymer substrate
US6792314B2 (en) 2001-06-18 2004-09-14 Alfred E. Mann Foundation For Scientific Research Miniature implantable array and stimulation system suitable for eyelid stimulation
US7190989B1 (en) 2001-06-21 2007-03-13 Advanced Neuromodulation Systems, Inc. Multi-channel flexible bio-probe and method of making the same
US6993392B2 (en) * 2002-03-14 2006-01-31 Duke University Miniaturized high-density multichannel electrode array for long-term neuronal recordings
US6907299B2 (en) 2002-05-24 2005-06-14 Shu-Chang Han Electrodes for a transcutaneous electrical nerve stimulator
US7006859B1 (en) * 2002-07-20 2006-02-28 Flint Hills Scientific, L.L.C. Unitized electrode with three-dimensional multi-site, multi-modal capabilities for detection and control of brain state changes
US7231259B2 (en) 2002-10-04 2007-06-12 Pacesetter, Inc. Body implantable lead comprising electrically conductive polymer conductors
US7212851B2 (en) * 2002-10-24 2007-05-01 Brown University Research Foundation Microstructured arrays for cortex interaction and related methods of manufacture and use
US7162308B2 (en) 2002-11-26 2007-01-09 Wilson Greatbatch Technologies, Inc. Nanotube coatings for implantable electrodes
US7337012B2 (en) * 2003-04-30 2008-02-26 Lawrence Livermore National Security, Llc Stretchable polymer-based electronic device
US7444184B2 (en) * 2003-05-11 2008-10-28 Neuro And Cardial Technologies, Llc Method and system for providing therapy for bulimia/eating disorders by providing electrical pulses to vagus nerve(s)
US7229437B2 (en) 2003-09-22 2007-06-12 St. Jude Medical, Atrial Fibrillation Division, Inc. Medical device having integral traces and formed electrodes
US7234225B2 (en) 2003-09-22 2007-06-26 St. Jude Medical, Atrial Fibrillation Division, Inc. Method for manufacturing medical device having embedded traces and formed electrodes
US7347826B1 (en) 2003-10-16 2008-03-25 Pacesetter, Inc. Packaging sensors for long term implant
US7548775B2 (en) 2003-10-21 2009-06-16 The Regents Of The University Of Michigan Intracranial neural interface system
US7236834B2 (en) 2003-12-19 2007-06-26 Medtronic, Inc. Electrical lead body including an in-line hermetic electronic package and implantable medical device using the same
US7107097B2 (en) 2004-01-14 2006-09-12 Northstar Neuroscience, Inc. Articulated neural electrode assembly
US20050182420A1 (en) 2004-02-13 2005-08-18 Schulte Gregory T. Low profile apparatus for securing a therapy delivery device within a burr hole
US20060058627A1 (en) 2004-08-13 2006-03-16 Flaherty J C Biological interface systems with wireless connection and related methods
US20060129056A1 (en) 2004-12-10 2006-06-15 Washington University Electrocorticography telemitter
TWI246914B (en) 2004-12-30 2006-01-11 Ind Tech Res Inst Flexible implantable electrical stimulator array
US7330756B2 (en) 2005-03-18 2008-02-12 Advanced Bionics Corporation Implantable microstimulator with conductive plastic electrode and methods of manufacture and use
US7774053B2 (en) 2005-03-31 2010-08-10 Wisconsin Alumni Research Foundation Neural probe array
US7536215B2 (en) 2005-05-19 2009-05-19 Ad-Tech Medical Instrument Corp. Cortical sensing device with pads
US20070123963A1 (en) * 2005-11-29 2007-05-31 Peter Krulevitch Method for producing flexible, stretchable, and implantable high-density microelectrode arrays
US7603153B2 (en) 2005-12-12 2009-10-13 Sterling Investments Lc Multi-element probe array
AU2007261319B2 (en) 2006-06-21 2012-02-09 Second Sight Medical Products, Inc. Flexible circuit electrode array with at least one tack opening
WO2009017844A1 (en) * 2007-08-01 2009-02-05 Ad-Tech Medical Instrument Corp. Wireless system for epilepsy monitoring and measurement
US20090254134A1 (en) * 2008-02-04 2009-10-08 Medtrode Inc. Hybrid ultrasound/electrode device for neural stimulation and recording

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6829498B2 (en) * 2000-03-29 2004-12-07 Arizona Board Of Regents Device for creating a neural interface and method for making same
US20030228748A1 (en) * 2002-05-23 2003-12-11 Nelson Richard A. Circuit elements having an ink receptive coating and a conductive trace and methods of manufacture

Cited By (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11273307B2 (en) 2009-10-20 2022-03-15 Nyxoah SA Method and device for treating sleep apnea
US10716940B2 (en) 2009-10-20 2020-07-21 Nyxoah SA Implant unit for modulation of small diameter nerves
US10751537B2 (en) 2009-10-20 2020-08-25 Nyxoah SA Arced implant unit for modulation of nerves
US10898717B2 (en) 2009-10-20 2021-01-26 Nyxoah SA Device and method for snoring detection and control
US9943686B2 (en) 2009-10-20 2018-04-17 Nyxoah SA Method and device for treating sleep apnea based on tongue movement
US9950166B2 (en) 2009-10-20 2018-04-24 Nyxoah SA Acred implant unit for modulation of nerves
US9849289B2 (en) 2009-10-20 2017-12-26 Nyxoah SA Device and method for snoring detection and control
US11857791B2 (en) 2009-10-20 2024-01-02 Nyxoah SA Arced implant unit for modulation of nerves
US10814137B2 (en) 2012-07-26 2020-10-27 Nyxoah SA Transcutaneous power conveyance device
US10716560B2 (en) 2012-07-26 2020-07-21 Nyxoah SA Implant unit delivery tool
US9855032B2 (en) 2012-07-26 2018-01-02 Nyxoah SA Transcutaneous power conveyance device
US10052097B2 (en) 2012-07-26 2018-08-21 Nyxoah SA Implant unit delivery tool
US11730469B2 (en) 2012-07-26 2023-08-22 Nyxoah SA Implant unit delivery tool
US10918376B2 (en) 2012-07-26 2021-02-16 Nyxoah SA Therapy protocol activation triggered based on initial coupling
US11253712B2 (en) 2012-07-26 2022-02-22 Nyxoah SA Sleep disordered breathing treatment apparatus
US10512782B2 (en) 2013-06-17 2019-12-24 Nyxoah SA Remote monitoring and updating of a medical device control unit
US11298549B2 (en) 2013-06-17 2022-04-12 Nyxoah SA Control housing for disposable patch
US11642534B2 (en) 2013-06-17 2023-05-09 Nyxoah SA Programmable external control unit
US9643022B2 (en) 2013-06-17 2017-05-09 Nyxoah SA Flexible control housing for disposable patch
CN111134671A (en) * 2019-12-27 2020-05-12 上海交通大学 Flexible multi-channel repeatable array type HD-sEMG sensor and preparation
US20230015298A1 (en) * 2021-07-13 2023-01-19 Biosense Webster (Isreal) Ltd. Ablation electrodes made from electrical traces of flexible printed circuit board

Also Published As

Publication number Publication date
US9061134B2 (en) 2015-06-23
US20110237921A1 (en) 2011-09-29

Similar Documents

Publication Publication Date Title
US9061134B2 (en) Systems and methods for flexible electrodes
Khalifa et al. The microbead: A 0.009 mm 3 implantable wireless neural stimulator
US9949376B2 (en) Cortical implant system for brain stimulation and recording
US20180345019A1 (en) Cortical interface for motor signal recording and sensory signal stimulation
US10130274B2 (en) PDMS-based stretchable multi-electrode and chemotrode array for epidural and subdural neuronal recording, electrical stimulation and drug delivery
Stieglitz Manufacturing, assembling and packaging of miniaturized neural implants
Guo et al. A PDMS-based integrated stretchable microelectrode array (isMEA) for neural and muscular surface interfacing
US8560041B2 (en) Biological interface system
EP2389101B1 (en) Pocket-enabled chip assembly for implantable devices
KR101327762B1 (en) Neuro device having nano wire and supporting layer
US8855737B2 (en) System and method for electrically shielding a microelectrode array in a physiological pathway from electrical noise
US20140277258A1 (en) Microfabricated surface neurostimulation device and methods of making and using the same
US20110307042A1 (en) Electrode arrays based on polyetherketoneketone
US20110251473A1 (en) Bipolar Sieve Electrode And Method Of Assembly
US20140343691A1 (en) Systems and Methods for a Wireless Myoelectric Implant
Zabihian et al. Implantable biomedical devices
Graudejus et al. A soft and stretchable bilayer electrode array with independent functional layers for the next generation of brain machine interfaces
Hoffmann et al. Introduction to Neuroprosthetics
EP4212205B1 (en) System for powering and controlling the electronics of minimally invasive stimulation or monitoring devices implantable in head or neck body regions
윤승현 A Fully Implantable Neural Stimulator for Brain Stimulation of Small Animal
Liu et al. Developing clinical grade flexible implantable electronics
Liu Fully-passive Wireless Acquisition of Biosignals
Krüger Investigation of electrodes as bidirectional human machine interface for neuro-technical control of prostheses

Legal Events

Date Code Title Description
AS Assignment

Owner name: RIPPLE LLC, UTAH

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:ASKIN, ROBERT E., III;HIATT, SCOTT D.;GUILLORY, KENNETH S.;AND OTHERS;REEL/FRAME:035776/0861

Effective date: 20101019

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION